<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Cannabis for the treatment of Crohn's disease - Kafil, TS - 2018 | Cochrane Library</title> <meta content="Cannabis for the treatment of Crohn's disease - Kafil, TS - 2018 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012853.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Cannabis for the treatment of Crohn's disease - Kafil, TS - 2018 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012853.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD012853.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Cannabis for the treatment of Crohn's disease" name="citation_title"/> <meta content="Tahir S Kafil" name="citation_author"/> <meta content="University of Western Ontario" name="citation_author_institution"/> <meta content="Tran M Nguyen" name="citation_author"/> <meta content="Robarts Clinical Trials" name="citation_author_institution"/> <meta content="John K MacDonald" name="citation_author"/> <meta content="jmacdon1@uwo.ca" name="citation_author_email"/> <meta content="Nilesh Chande" name="citation_author"/> <meta content="London Health Sciences Centre ‐ Victoria Hospital" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="11" name="citation_issue"/> <meta content="10.1002/14651858.CD012853.pub2" name="citation_doi"/> <meta content="2018" name="citation_date"/> <meta content="2018/11/08" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012853.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012853.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012853.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Phytotherapy [adverse effects]; Cannabidiol [adverse effects, *therapeutic use]; Crohn Disease [*drug therapy]; Disease Progression; Dronabinol [adverse effects, *therapeutic use]; Marijuana Smoking; Medical Marijuana [adverse effects, *therapeutic use]; Quality of Life; Randomized Controlled Trials as Topic; Remission Induction" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012853.pub2&amp;doi=10.1002/14651858.CD012853.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012853.pub2&amp;doi=10.1002/14651858.CD012853.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012853.pub2&amp;doi=10.1002/14651858.CD012853.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012853.pub2&amp;doi=10.1002/14651858.CD012853.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012853.pub2&amp;doi=10.1002/14651858.CD012853.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012853.pub2&amp;doi=10.1002/14651858.CD012853.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012853.pub2&amp;doi=10.1002/14651858.CD012853.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012853.pub2&amp;doi=10.1002/14651858.CD012853.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012853.pub2&amp;doi=10.1002/14651858.CD012853.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012853.pub2&amp;doi=10.1002/14651858.CD012853.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012853.pub2&amp;doi=10.1002/14651858.CD012853.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012853.pub2&amp;doi=10.1002/14651858.CD012853.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012853.pub2&amp;doi=10.1002/14651858.CD012853.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012853.pub2&amp;doi=10.1002/14651858.CD012853.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012853.pub2&amp;doi=10.1002/14651858.CD012853.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012853.pub2&amp;doi=10.1002/14651858.CD012853.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012853.pub2&amp;doi=10.1002/14651858.CD012853.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012853.pub2&amp;doi=10.1002/14651858.CD012853.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012853.pub2&amp;doi=10.1002/14651858.CD012853.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012853.pub2&amp;doi=10.1002/14651858.CD012853.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012853.pub2&amp;doi=10.1002/14651858.CD012853.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012853.pub2&amp;doi=10.1002/14651858.CD012853.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012853.pub2&amp;doi=10.1002/14651858.CD012853.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="fw9sVDQH";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD012853\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD012853\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012853\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012853\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ms","ja","hr","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD012853.pub2",title:"Cannabis for the treatment of Crohn\u0027s disease",firstPublishedDate:"Nov 8, 2018 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Gut Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=fw9sVDQH&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012853.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012853.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD012853.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD012853.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012853.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD012853.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD012853.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD012853.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD012853.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD012853.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>12671 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD012853.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012853.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012853.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012853.pub2/full#CD012853-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012853.pub2/full#CD012853-sec-0070"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012853.pub2/full#CD012853-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012853.pub2/full#CD012853-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012853.pub2/full#CD012853-sec-0028"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012853.pub2/full#CD012853-sec-0029"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012853.pub2/full#CD012853-sec-0052"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012853.pub2/full#CD012853-sec-0064"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012853.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012853.pub2/appendices#CD012853-sec-0075"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012853.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012853.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/table_n/CD012853StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/table_n/CD012853StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012853.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012853.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012853.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012853.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012853.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD012853.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Cannabis for the treatment of Crohn's disease</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012853.pub2/information#CD012853-cr-0002">Tahir S Kafil</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012853.pub2/information#CD012853-cr-0003">Tran M Nguyen</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012853.pub2/information#CD012853-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>John K MacDonald</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012853.pub2/information#CD012853-cr-0005">Nilesh Chande</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/information/en#CD012853-sec-0080">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 08 November 2018 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD012853.pub2">https://doi.org/10.1002/14651858.CD012853.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD012853-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012853-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012853-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012853-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012853-abs-0011">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD012853-abs-0001" lang="en"> <section id="CD012853-sec-0001"> <h3 class="title" id="CD012853-sec-0001">Background</h3> <p>Crohn's disease (CD) is a chronic immune‐mediated condition of transmural inflammation in the gastrointestinal tract, associated with significant morbidity and decreased quality of life. The endocannabinoid system provides a potential therapeutic target for cannabis and cannabinoids and animal models have shown benefit in decreasing inflammation. However, there is also evidence to suggest transient adverse events such as weakness, dizziness and diarrhea, and an increased risk of surgery in people with CD who use cannabis. </p> </section> <section id="CD012853-sec-0002"> <h3 class="title" id="CD012853-sec-0002">Objectives</h3> <p>The objectives were to assess the efficacy and safety of cannabis and cannabinoids for induction and maintenance of remission in people with CD. </p> </section> <section id="CD012853-sec-0003"> <h3 class="title" id="CD012853-sec-0003">Search methods</h3> <p>We searched MEDLINE, Embase, AMED, PsychINFO, the Cochrane IBD Group Specialized Register, CENTRAL, ClinicalTrials.Gov, and the European Clinical Trials Register up to 17 October 2018. We searched conference abstracts, references and we also contacted researchers in this field for upcoming publications. </p> </section> <section id="CD012853-sec-0004"> <h3 class="title" id="CD012853-sec-0004">Selection criteria</h3> <p>Randomized controlled trials comparing any form of cannabis or its cannabinoid derivatives (natural or synthetic) to placebo or an active therapy for adults with Crohn’s disease were included. </p> </section> <section id="CD012853-sec-0005"> <h3 class="title" id="CD012853-sec-0005">Data collection and analysis</h3> <p>Two authors independently screened search results, extracted data and assessed bias using the Cochrane risk of bias tool. The primary outcomes were clinical remission and relapse. Remission is commonly defined as a Crohn's disease activity index (CDAI) of &lt; 150. Relapse is defined as a CDAI &gt; 150. Secondary outcomes included clinical response, endoscopic remission, endoscopic improvement, histological improvement, quality of life, C‐reactive protein (CRP) and fecal calprotectin measurements, adverse events (AEs), serious AEs, withdrawal due to AEs, and cannabis dependence and withdrawal effects. We calculated the risk ratio (RR) and corresponding 95% confidence interval (95% CI) for dichotomous outcomes. For continuous outcomes, we calculated the mean difference (MD) and 95% CI. Data were combined for analysis when the interventions, patient groups and outcomes were sufficiently similar (determined by consensus). Data were analyzed on an intention‐to‐treat basis and the overall certainty of the evidence supporting the outcomes was evaluated using the GRADE criteria. </p> </section> <section id="CD012853-sec-0006"> <h3 class="title" id="CD012853-sec-0006">Main results</h3> <p>Three studies (93 participants) that assessed cannabis in people with active CD met the inclusion criteria. One ongoing study was also identified. Participants in two of the studies were adults with active Crohn's disease who had failed at least one medical treatment. The inclusion criteria for the third study were unclear. No studies that assessed cannabis therapy in quiescent CD were identified. The studies were not pooled due to differences in the interventional drug. </p> <p>One small study (N = 21) compared eight weeks of treatment with cannabis cigarettes containing 115 mg of D9‐tetrahydrocannabinol (THC) to placebo cigarettes containing cannabis with the THC removed in participants with active CD. This study was rated as high risk of bias for blinding and other bias (cannabis participants were older than placebo). The effects of cannabis on clinical remission were unclear. Forty‐five per cent (5/11) of the cannabis group achieved clinical remission compared with 10% (1/10) of the placebo group (RR 4.55, 95% CI 0.63 to 32.56; very low certainty evidence). A difference was observed in clinical response (decrease in CDAI score of &gt;100 points) rates. Ninety‐one per cent (10/11) of the cannabis group achieved a clinical response compared to 40% (4/10) of the placebo group (RR 2.27, 95% CI 1.04 to 4.97; very low certainty evidence). More AEs were observed in the cannabis cigarette group compared to placebo (RR 4.09, 95% CI 1.15 to 14.57; very low certainty evidence). These AEs were considered to be mild in nature and included sleepiness, nausea, difficulty with concentration, memory loss, confusion and dizziness. This study did not report on serious AEs or withdrawal due to AEs. </p> <p>One small study (N = 22) compared cannabis oil (5% cannabidiol) to placebo oil in people with active CD. This study was rated as high risk of bias for other bias (cannabis participants were more likely than placebo participants to be smokers). There was no difference in clinical remission rates. Forty per cent (4/10) of cannabis oil participants achieved remission at 8 weeks compared to 33% (3/9) of the placebo participants (RR 1.20, 95% CI 0.36 to 3.97; very low certainty evidence). There was no difference in the proportion of participants who had a serious adverse event. Ten per cent (1/10) of participants in the cannabis oil group had a serious adverse event compared to 11% (1/9) of placebo participants (RR 0.90, 95% CI 0.07 to 12.38, very low certainty evidence). Both serious AEs were worsening Crohn's disease that required rescue intervention. This study did not report on clinical response, CRP, quality of life or withdrawal due to AEs. </p> <p>One small study (N= 50) compared cannabis oil (15% cannabidiol and 4% THC) to placebo in participants with active CD. This study was rated as low risk of bias. Differences in CDAI and quality of life scores measured by the SF‐36 instrument were observed. The mean quality of life score after 8 weeks of treatment was 96.3 in the cannabis oil group compared to 79.9 in the placebo group (MD 16.40, 95% CI 5.72 to 27.08, low certainty evidence). After 8 weeks of treatment, the mean CDAI score was118.6 in the cannabis oil group compared to 212.6 in the placebo group (MD ‐94.00, 95%CI ‐148.86 to ‐39.14, low certainty evidence). This study did not report on clinical remission, clinical response, CRP or AEs. </p> </section> <section id="CD012853-sec-0007"> <h3 class="title" id="CD012853-sec-0007">Authors' conclusions</h3> <p>The effects of cannabis and cannabis oil on Crohn's disease are uncertain. Thus no firm conclusions regarding the efficacy and safety of cannabis and cannabis oil in adults with active Crohn's disease can be drawn. The effects of cannabis or cannabis oil in quiescent Crohn's disease have not been investigated. Further studies with larger numbers of participants are required to assess the potential benefits and harms of cannabis in Crohn's disease. Future studies should assess the effects of cannabis in people with active and quiescent Crohn's disease. Different doses of cannabis and delivery modalities should be investigated. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD012853-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012853-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD012853-abs-0004">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD012853-abs-0008">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012853-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hr#CD012853-abs-0007">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD012853-abs-0006">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD012853-abs-0005">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012853-abs-0012">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD012853-abs-0003" lang="en"> <h3>Cannabis and cannabis oil for the treatment of Crohn's disease</h3> <p><b>What is Crohn's disease?</b> </p> <p>Crohn’s disease is a long‐term condition that results in inflammation of the gastrointestinal tract, occurring anywhere from the mouth to the anus. Common symptoms include fever, diarrhoea, abdominal pain and weight loss. Crohn's disease is characterized by periods of relapse when people are actively experiencing symptoms and periods of remission when the symptoms stop. </p> <p><b>What are Cannabis and Cannabinoids?</b> </p> <p>Cannabis is a widely used drug which acts on the endocannabinoid system. Cannabis contains multiple components called cannabinoids. The use of cannabis and cannabis oil containing specific cannabinoids produces mental and physical effects such as altered sensory perception and euphoria when consumed. Some cannabinoids, such as cannabidiol, do not have a psychoactive effect. Cannabis and cannabidiol have some anti‐inflammatory properties that might help people with Crohn's disease. </p> <p><b>What did the researchers investigate?</b> </p> <p>The researchers studied whether cannabis is better than placebo (e.g. a sugar pill) therapy for treating adults with active Crohn's disease or Crohn's disease that is in remission. </p> <p><b>What did the researchers find?</b> </p> <p>The researchers extensively searched the literature up to 17 October 2018 and found three studies (93 participants) that met the inclusion criteria. One ongoing study was also identified. All of the studies were small in size and had some quality issues. One small study (21 participants) compared eight weeks of treatment with cannabis cigarettes containing 115 mg of D9‐tetrahydrocannabinol (THC) to placebo cigarettes containing cannabis with the THC removed in participants with active Crohn's disease who had failed at least one medical treatment. Although no difference in clinical remission rates was observed, more participants in the cannabis group had improvement in their Crohn's disease symptoms than participants in the placebo group. More side effects were observed in the cannabis cigarette group compared to placebo. These side effects were considered to be mild in nature and included sleepiness, nausea, difficulty with concentration, memory loss, confusion and dizziness. Participants in the cannabis cigarette group reported improvements in pain, appetite and satisfaction with treatment. </p> <p>One small study (22 participants) compared cannabis oil (10 mg of cannabidiol twice daily) to placebo oil (i.e. olive oil) in participants with active Crohn's disease who had failed at least one medical treatment. No difference in clinical remission rates was observed. There was no difference in serious side effects. Serious side effects included worsening Crohn's disease in one participant in each group. </p> <p>One small study (50 participants) compared cannabis oil (composed of 15% cannabidiol and 4% THC) to placebo oil in participants with active Crohn's disease. Positive differences in quality of life and the Crohn's disease activity index were observed. </p> <p><b>Conclusions</b> </p> <p>The effects of cannabis and cannabis oil on Crohn's disease are uncertain. No firm conclusions regarding the benefits and harms (e.g. side effects) of cannabis and cannabis oil in adults with Crohn's disease can be drawn. The effects of cannabis and cannabis oil in people with Crohn's disease in remission have not been investigated. Further studies with larger numbers of participants are required to assess the potential benefits and harms of cannabis in Crohn's disease. Future studies should assess the effects of cannabis in people with active and inactive Crohn's disease. Different doses of cannabis and formulations (e.g. cannabis oil or pills) should be investigated. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD012853-sec-0070" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD012853-sec-0070"></div> <h3 class="title" id="CD012853-sec-0071">Implications for practice</h3> <section id="CD012853-sec-0071"> <p>The effects of cannabis and cannabis oil on Crohn's disease are uncertain. Thus no firm conclusions regarding the efficacy and safety of cannabis and cannabis oil in adults with active Crohn's disease can be drawn. There is no evidence for cannabis or cannabinoid use for maintenance of remission in Crohn's disease. </p> </section> <h3 class="title" id="CD012853-sec-0072">Implications for research</h3> <section id="CD012853-sec-0072"> <p>Further studies with larger numbers of participants are required to assess the potential benefits and harms of cannabis in Crohn's disease. Research from different investigator groups will be helpful to assess for reproducibility of results. Future studies should assess the effects of cannabis in people with both active and quiescent Crohn's disease. Different doses of cannabis and delivery modalities should be investigated. Future RCTs should more clearly assess adverse events. Long‐term follow‐up is needed to assess both self‐reported and objective measurements of withdrawal, safety outcomes, consequences in terms of cognitive function, and capacity to function in activities of daily living while using cannabis. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD012853-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD012853-sec-0022"></div> <div class="table" id="CD012853-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Cannabis cigarettes (115 mg THC) compared to placebo cigarettes for the treatment of active Crohn's disease</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Cannabis cigarettes (115 mg THC) compared to placebo cigarettes for the treatment of active Crohn's disease</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> participants with active Crohn's disease<br/> <b>Setting:</b> outpatient<br/> <b>Intervention:</b> Cannabis cigarettes (115 mg THC)<br/> <b>Comparison:</b> placebo cigarettes </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo cigarettes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with cannabis cigarettes (115 mg THC)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of patients achieving clinical remission</p> <p>Follow‐up: 8 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>100 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>455 per 1,000<br/> (63 to 1,000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 4.55<br/> (0.63 to 32.56) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Remission was defined as a CDAI score &lt; 150</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of patients achieving clinical response</p> <p>Follow‐up: 8 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>400 per 1,000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>908 per 1,000<br/> (416 to 1,000) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 2.27<br/> (1.04 to 4.97) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21<br/> (1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Response was defined as a 100‐point reduction of CDAI from baseline</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CRP (mg/dL) at end of study</p> <p>Follow‐up: 8 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>200 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>272 per 1,000<br/> (56 to 1,000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.36<br/> (0.28 to 6.56) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>4 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This study reported on the proportion of participants with a decrease in CRP of more than 0.5mg/dL from week 0 to week 8 </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life</p> <p>Short‐Form 36 health survey (SF‐36)</p> <p>Follow‐up: 8 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SF‐36 scores range from 0 to 100 with a higher score indicating better quality of life </p> <p>This study reported a 28 point increase in the SF‐36 score from baseline in the cannabis group compared to a 5 point increase in the placebo group (standard deviations were not reported) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> <p>Follow‐up: 8 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>200 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>818 per 1,000<br/> (230 to 1,000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 4.09<br/> (1.15 to 14.57) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events included sleepiness, nausea, difficulty with concentration, memory loss, confusion and dizziness </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>This outcome was not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Withdrawal due to adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>This outcome was not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>CDAI: Crohn's disease activity index</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded one level due to high risk of bias for blinding of participants and other bias (cannabis participants were about 10 years older than placebo participants) </p> <p><sup>2</sup> Downgraded two levels due to very serious imprecision (6 events) </p> <p><sup>3</sup> Downgraded two levels due to very serious imprecision (14 events) </p> <p><sup>4</sup> We did not downgrade for risk of bias as this would have no impact on CRP which is an objective outcome </p> <p><sup>5</sup> Downgraded two levels due to very serious imprecision (5 events) </p> <p><sup>6</sup> Downgraded two levels due to very serious imprecision (11 events) </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012853-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Cannabis oil (5% cannabidiol sublingual oil) compared to placebo oil for the treatment of active Crohn's disease</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Cannabis oil (5% cannabidiol sublingual oil) compared to placebo for the treatment of active Crohn's disease</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> participants with active Crohn's disease<br/> <b>Setting:</b> outpatient<br/> <b>Intervention:</b> cannabis oil (5% cannabidiol sublingual oil)<br/> <b>Comparison:</b> placebo oil (olive oil) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with cannabis oil (5% cannabidiol sublingual oil)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of patients achieving clinical remission</p> <p>Follow‐up: 8 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>333 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>400 per 1,000<br/> (120 to 1,000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.20<br/> (0.36 to 3.97) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Remission was defined as a CDAI score &lt; 150</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of patients achieving clinical response</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>This outcome was not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CRP (mg/dL) at end of study</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>This outcome was not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Quality of life</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>This outcome was not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse events</p> <p>Follow‐up: 8 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>See comments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse events were rated on a scale from one to seven and included headache, sleepiness, nausea and dizziness </p> <p>The proportion of participants in each group who had an adverse event was not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious adverse events</p> <p>Follow‐up: 8 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>111 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>100 per 1,000<br/> (8 to 1,000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.90<br/> (0.07 to 12.38) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was one serious adverse event in each group. Both were worsening Crohn's disease that required rescue intervention </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Withdrawal due to adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>This outcome was not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded one level due to high risk of bias for other bias (60% of cannabis participants were smokers compared to none of the placebo participants) </p> <p><sup>2</sup> Downgraded two levels due to very serious imprecision (7 events) </p> <p><sup>3</sup> Downgraded two levels due to very serious imprecision (2 events) </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012853-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Cannabis oil (15% cannabidiol and 4% THC) compared to placebo oil for the treatment of active Crohn's disease</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Cannabis oil (15% cannabidiol and 4% THC) compared to placebo oil for the treatment of active Crohn's disease</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> participants with active Crohn's disease<br/> <b>Setting:</b> outpatient<br/> <b>Intervention:</b> cannabis oil (15% cannabidiol and 4% THC)<br/> <b>Comparison:</b> placebo oil (olive oil) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo oil</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with cannabis oil (15% cannabidiol and 4% THC)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of patients achieving clinical remission</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>This outcome was not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of patients achieving clinical response</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>This outcome was not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CRP (mg/dL) at end of study</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>This outcome was not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life</p> <p>Short‐Form 36 health survey (SF‐36)</p> <p>Follow‐up: 8 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean SF‐36 score at 8 weeks was 79.9</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 16.4 higher<br/> (5.72 higher to 27.08 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SF‐36 scores range from 0 to 100 with a higher score indicating better quality of life </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This outcome was not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>This outcome was not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Withdrawal due to adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>This outcome was not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded two levels due to very serious imprecision (39 participants) </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD012853-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD012853-sec-0023"></div> <p>Cannabis is a widely used recreational drug which alters sensory perception and causes euphoria (<a href="./references#CD012853-bbs2-0038" title="Tibirica , E . The multiple functions of the endocannabinoid system: a focus on the regulation of food intake. Diabetology and Metabolic Syndrome2010;2:5. ">Tibirica 2010</a>). It has been promoted as a treatment for a variety of diseases such as cancer, glaucoma and autoimmune diseases (<a href="./references#CD012853-bbs2-0020" title="HillKP . Medical marijuana for treatment of chronic pain and other medical and psychiatric problems: A clinical review. JAMA2015;313(24):2474‐83. ">Hill 2015</a>). Cannabis has also been hypothesized to improve disease activity in Crohn’s disease via modulation of the endocannabinoid system (<a href="./references#CD012853-bbs2-0038" title="Tibirica , E . The multiple functions of the endocannabinoid system: a focus on the regulation of food intake. Diabetology and Metabolic Syndrome2010;2:5. ">Tibirica 2010</a>). The endocannabinoid system has been shown to help regulate brain function and the immune system (<a href="./references#CD012853-bbs2-0024" title="KleinTW , CarbralGA . Cannabinoid‐Induced immune suppression and modulation of antigen‐presenting cells. Journal of Neuroimmune Pharmacology2006;1:50‐64. ">Klein 2006</a>). </p> <p>Studies have found a higher prevalence of cannabis use in people with IBD who claim it relieves symptoms such as abdominal pain, diarrhoea, and reduced appetite (<a href="./references#CD012853-bbs2-0026" title="LalS , PrasadN , RyanM , TangriS , SilverbergMS , GordonA , et al. Cannabis use amongst patients with inflammatory bowel disease. European Journal of Gastroenterology and Hepatology2011;23(10):891‐6. ">Lal 2011</a>; <a href="./references#CD012853-bbs2-0042" title="WeissA , FriedenbergF . Patterns of cannabis use in patients with Inflammatory Bowel Disease: A population based analysis. Drug and Alcohol Dependence2015;156:84‐9. ">Weiss 2015</a>). It is unclear if this is due to the known psychotropic effects of cannabis such as analgesia and euphoria or if it is related to anti‐inflammatory effects demonstrated in recent studies and experimental animal models (<a href="./references#CD012853-bbs2-0016" title="HasenoehrlC , TaschlerU , StorrM , SchichoR . The gastrointestinal tract – a central organ of cannabinoid signaling in health and disease. Journal of Neurogastroenterology and Motility2016;28(12):1765‐80. ">Hasenoehrl 2016</a>; <a href="./references#CD012853-bbs2-0024" title="KleinTW , CarbralGA . Cannabinoid‐Induced immune suppression and modulation of antigen‐presenting cells. Journal of Neuroimmune Pharmacology2006;1:50‐64. ">Klein 2006</a>; <a href="./references#CD012853-bbs2-0036" title="SinghUP , SinghNP , SinghB , PriceRL , NagarkattiM , NagarkattiPS . Cannabinoids Receptor‐2 (CB2) agonist ameliorates colitis inIL‐10−/− mice by attenuating the activation of T cells and promoting their apoptosis. Toxicology and Applied Pharmacology2012;258(2):256–67. ">Singh 2012</a>). There is also evidence that cannabis use in people with Crohn's disease has potential for harm. Cannabis has been associated with higher risk of surgery in people with Crohn's disease (<a href="./references#CD012853-bbs2-0037" title="StorrM , DevlinS , KaplanGG , PanaccioneR , AndrewsCN . Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn’s disease. Inflammatory Bowel Diseases2014;20(3):472–80. ">Storr 2014</a>). Cannabinoids have been associated with an increased risk of transient adverse events including weakness, dizziness, and diarrhea (<a href="./references#CD012853-bbs2-0043" title="WhitingPF , WolffRF , DeshpandeS , DiNisioM , DuffyS , HernandezA , et al. Cannabinoids for medical use a systematic review and meta‐analysis. JAMA2015;313(24):2456‐73. ">Whiting 2015</a>). Despite these conflicting data, physicians are often asked to prescribe cannabis in the context of a rapidly growing medical cannabis industry (<a href="./references#CD012853-bbs2-0011" title="FletcherJ . Marijuana is not a prescription medicine. Canadian Medical Association Journal2013;185(5):369. ">Fletcher 2013</a>). </p> <p>There were no placebo‐controlled trials evaluating the use of cannabis in people with IBD until the first randomized, prospective, placebo‐controlled trial was published in 2013 (Naftali 2013). This study raised important questions regarding the exact role of cannabis in treating people with Crohn's disease: Does cannabis lead to symptomatic improvement only or does it also objectively reduce inflammation? Is cannabis safe when used by people with Crohn's disease? </p> <section id="CD012853-sec-0024"> <h3 class="title" id="CD012853-sec-0024">Description of the condition</h3> <p>Crohn’s disease (CD) is a chronic immune‐mediated condition of transmural inflammation in the gastrointestinal tract. CD is associated with significant morbidity and decreased quality of life (<a href="./references#CD012853-bbs2-0025" title="LahatA , LangA , Ben‐HorinS . Impact of cannabis treatment on the quality of life, weight and clinical disease activity in Inflammatory Bowel Disease patients: A pilot prospective study. Digestion2012;85:1‐8. ">Lahat 2012</a>; <a href="./references#CD012853-bbs2-0032" title="RubinGP , HunginAP , ChinnDJ , DwarakanathD . Quality of life in patients with established inflammatory bowel disease: a UK general practice survey. Alimentary Pharmacology and Therapeutics2004;19(5):529‐35. ">Rubin 2004</a>). In North America, the prevalence of CD is estimated to range from 26 to 199 cases per 100,000 person‐years (<a href="./references#CD012853-bbs2-0012" title="FriedmanS , BlumbergRS . Chapter 295: Inflammatory Bowel Disease. Harrison’s Principles of Internal Medicine. 18th Edition. The McGraw‐Hill Companies, 2012. ">Friedman 2012</a>). </p> <p>CD can affect anywhere from the mouth to the perianal area. The pathophysiology of this condition is multifactorial and people may have a genetic predisposition (<a href="./references#CD012853-bbs2-0012" title="FriedmanS , BlumbergRS . Chapter 295: Inflammatory Bowel Disease. Harrison’s Principles of Internal Medicine. 18th Edition. The McGraw‐Hill Companies, 2012. ">Friedman 2012</a>). CD is thought to arise from a dysregulated immune response towards commensal microbiota and dietary contents in the gastrointestinal tract (<a href="./references#CD012853-bbs2-0012" title="FriedmanS , BlumbergRS . Chapter 295: Inflammatory Bowel Disease. Harrison’s Principles of Internal Medicine. 18th Edition. The McGraw‐Hill Companies, 2012. ">Friedman 2012</a>). This leads to an inappropriate inflammatory cascade of activated T cells secreting excessive pro‐inflammatory cytokines such as interleukin‐1 (IL‐1), IL‐6, and tumor necrosis factor‐alpha (TNF‐α) (<a href="./references#CD012853-bbs2-0012" title="FriedmanS , BlumbergRS . Chapter 295: Inflammatory Bowel Disease. Harrison’s Principles of Internal Medicine. 18th Edition. The McGraw‐Hill Companies, 2012. ">Friedman 2012</a>). This results in damage to previously healthy tissues. </p> <p>CD is characterized by periods of relapse and remission (<a href="./references#CD012853-bbs2-0012" title="FriedmanS , BlumbergRS . Chapter 295: Inflammatory Bowel Disease. Harrison’s Principles of Internal Medicine. 18th Edition. The McGraw‐Hill Companies, 2012. ">Friedman 2012</a>). Symptoms may include low grade fevers, malaise, diarrhea, crampy abdominal pain, or hematochezia (<a href="./references#CD012853-bbs2-0012" title="FriedmanS , BlumbergRS . Chapter 295: Inflammatory Bowel Disease. Harrison’s Principles of Internal Medicine. 18th Edition. The McGraw‐Hill Companies, 2012. ">Friedman 2012</a>). The site of inflammation influences the symptoms. Complications of CD include fistula and abscess formation, perforations and fibrotic strictures (<a href="./references#CD012853-bbs2-0012" title="FriedmanS , BlumbergRS . Chapter 295: Inflammatory Bowel Disease. Harrison’s Principles of Internal Medicine. 18th Edition. The McGraw‐Hill Companies, 2012. ">Friedman 2012</a>; <a href="./references#CD012853-bbs2-0025" title="LahatA , LangA , Ben‐HorinS . Impact of cannabis treatment on the quality of life, weight and clinical disease activity in Inflammatory Bowel Disease patients: A pilot prospective study. Digestion2012;85:1‐8. ">Lahat 2012</a>). </p> <p>Usual treatment options for CD include anti‐inflammatory and immunosuppressant agents (<a href="./references#CD012853-bbs2-0012" title="FriedmanS , BlumbergRS . Chapter 295: Inflammatory Bowel Disease. Harrison’s Principles of Internal Medicine. 18th Edition. The McGraw‐Hill Companies, 2012. ">Friedman 2012</a>). Commonly used drugs are aminosalicylates, sulfasalazine, corticosteroids, thiopurine drugs, methotrexate and biologic therapies such as anti‐TNF‐α agents (<a href="./references#CD012853-bbs2-0012" title="FriedmanS , BlumbergRS . Chapter 295: Inflammatory Bowel Disease. Harrison’s Principles of Internal Medicine. 18th Edition. The McGraw‐Hill Companies, 2012. ">Friedman 2012</a>). Management includes control of acute exacerbations, induction of remission, and maintenance of remission. </p> </section> <section id="CD012853-sec-0025"> <h3 class="title" id="CD012853-sec-0025">Description of the intervention</h3> <p>Cannabis sativa consists of numerous compounds called cannabinoids, of which delta 9‐tetrahydrocannabinol (THC) is the main psychotropic component (<a href="./references#CD012853-bbs2-0024" title="KleinTW , CarbralGA . Cannabinoid‐Induced immune suppression and modulation of antigen‐presenting cells. Journal of Neuroimmune Pharmacology2006;1:50‐64. ">Klein 2006</a>). Many natural and synthetic cannabinoids have been found and studied including cannabidiol, cannabinol, cannabigerol, and dronabinol (<a href="./references#CD012853-bbs2-0024" title="KleinTW , CarbralGA . Cannabinoid‐Induced immune suppression and modulation of antigen‐presenting cells. Journal of Neuroimmune Pharmacology2006;1:50‐64. ">Klein 2006</a>). Some of these cannabinoids are psychoactive, whereas others are not (<a href="./references#CD012853-bbs2-0024" title="KleinTW , CarbralGA . Cannabinoid‐Induced immune suppression and modulation of antigen‐presenting cells. Journal of Neuroimmune Pharmacology2006;1:50‐64. ">Klein 2006</a>). Multiple experimental animal models have shown anti‐inflammatory properties of various cannabinoids (<a href="./references#CD012853-bbs2-0024" title="KleinTW , CarbralGA . Cannabinoid‐Induced immune suppression and modulation of antigen‐presenting cells. Journal of Neuroimmune Pharmacology2006;1:50‐64. ">Klein 2006</a>). </p> </section> <section id="CD012853-sec-0026"> <h3 class="title" id="CD012853-sec-0026">How the intervention might work</h3> <p>The endocannabinoid system helps regulate the central nervous sytem, peripheral tissues, and multiple immune cells (<a href="./references#CD012853-bbs2-0038" title="Tibirica , E . The multiple functions of the endocannabinoid system: a focus on the regulation of food intake. Diabetology and Metabolic Syndrome2010;2:5. ">Tibirica 2010</a>). This system consists of cannabinoid (CB) receptors 1 and 2, several endogenous ligands called 'endocannabinoids', and associated enzymes (<a href="./references#CD012853-bbs2-0016" title="HasenoehrlC , TaschlerU , StorrM , SchichoR . The gastrointestinal tract – a central organ of cannabinoid signaling in health and disease. Journal of Neurogastroenterology and Motility2016;28(12):1765‐80. ">Hasenoehrl 2016</a>; <a href="./references#CD012853-bbs2-0024" title="KleinTW , CarbralGA . Cannabinoid‐Induced immune suppression and modulation of antigen‐presenting cells. Journal of Neuroimmune Pharmacology2006;1:50‐64. ">Klein 2006</a>). Multiple studies have shown that the endocannabinoid system helps control physiologic functions of the gut including motility, secretion and epithelial barrier integrity (<a href="./references#CD012853-bbs2-0008" title="CouttsAA , PertweeRG . Evidence that cannabinoid‐induced inhibition of electrically evoked contractions of the myenteric plexus ‐ longitudinal muscle preparation of guinea‐pig small intestine can be modulated by Ca2+ and cAMP. Canadian Journal of Physiology and Pharmacology1998;76:340–6. ">Coutts 1998</a>; <a href="./references#CD012853-bbs2-0016" title="HasenoehrlC , TaschlerU , StorrM , SchichoR . The gastrointestinal tract – a central organ of cannabinoid signaling in health and disease. Journal of Neurogastroenterology and Motility2016;28(12):1765‐80. ">Hasenoehrl 2016</a>; <a href="./references#CD012853-bbs2-0030" title="PintoL , IzzoAA , MascoloN , CapassoF , CascioMG , BisognoT , et al. Endocannabinoids as physiological regulators of colonic propulsion in mice. Gastroenterology2002;123:227–34. ">Pinto 2002</a>; <a href="./references#CD012853-bbs2-0040" title="ViannaCR , DonatoJ , RossiJ , ScottM , EconomidesK , GautronL , et al. Cannabinoid receptor 1 in the vagus nerve is dispensable for body weight homeostasis but required for normal gastrointestinal motility. Journal of Neuroscience2012;32(30):10331–7. ">Vianna 2012</a>). This makes the endocannabinoid system a potential therapeutic target for gastrointestinal diseases. Cannabis and cannabinoids appear to influence this system via CB1 and CB2 receptors and other mechanisms (<a href="./references#CD012853-bbs2-0016" title="HasenoehrlC , TaschlerU , StorrM , SchichoR . The gastrointestinal tract – a central organ of cannabinoid signaling in health and disease. Journal of Neurogastroenterology and Motility2016;28(12):1765‐80. ">Hasenoehrl 2016</a>; <a href="./references#CD012853-bbs2-0024" title="KleinTW , CarbralGA . Cannabinoid‐Induced immune suppression and modulation of antigen‐presenting cells. Journal of Neuroimmune Pharmacology2006;1:50‐64. ">Klein 2006</a>). </p> <p>CB1 receptors are widely expressed in the gastrointestinal tract, central nervous system and peripheral tissues such as blood vessels (<a href="./references#CD012853-bbs2-0016" title="HasenoehrlC , TaschlerU , StorrM , SchichoR . The gastrointestinal tract – a central organ of cannabinoid signaling in health and disease. Journal of Neurogastroenterology and Motility2016;28(12):1765‐80. ">Hasenoehrl 2016</a>; <a href="./references#CD012853-bbs2-0024" title="KleinTW , CarbralGA . Cannabinoid‐Induced immune suppression and modulation of antigen‐presenting cells. Journal of Neuroimmune Pharmacology2006;1:50‐64. ">Klein 2006</a>). In the GI tract, the CB1 receptors are found in the enteric nervous system, the epithelial lining, plasma cells, and smooth muscle cells of blood vessels (<a href="./references#CD012853-bbs2-0016" title="HasenoehrlC , TaschlerU , StorrM , SchichoR . The gastrointestinal tract – a central organ of cannabinoid signaling in health and disease. Journal of Neurogastroenterology and Motility2016;28(12):1765‐80. ">Hasenoehrl 2016</a>). CB1 receptor activation may reduce gastric emptying, intestinal transit time, as well as reduce colonic propulsion (<a href="./references#CD012853-bbs2-0030" title="PintoL , IzzoAA , MascoloN , CapassoF , CascioMG , BisognoT , et al. Endocannabinoids as physiological regulators of colonic propulsion in mice. Gastroenterology2002;123:227–34. ">Pinto 2002</a>). The brain‐gut axis also influences motility and CB1 receptors in the vagus nerve are part of normal motility (<a href="./references#CD012853-bbs2-0040" title="ViannaCR , DonatoJ , RossiJ , ScottM , EconomidesK , GautronL , et al. Cannabinoid receptor 1 in the vagus nerve is dispensable for body weight homeostasis but required for normal gastrointestinal motility. Journal of Neuroscience2012;32(30):10331–7. ">Vianna 2012</a>). CB1 receptors modulate the release of multiple neurotransmitters in the central nervous system causing central effects such as a reduction in pain and nausea (<a href="./references#CD012853-bbs2-0024" title="KleinTW , CarbralGA . Cannabinoid‐Induced immune suppression and modulation of antigen‐presenting cells. Journal of Neuroimmune Pharmacology2006;1:50‐64. ">Klein 2006</a>; <a href="./references#CD012853-bbs2-0038" title="Tibirica , E . The multiple functions of the endocannabinoid system: a focus on the regulation of food intake. Diabetology and Metabolic Syndrome2010;2:5. ">Tibirica 2010</a>). Activation of the CB1 receptor may enhance epithelial wound closure in the colon (<a href="./references#CD012853-bbs2-0044" title="WrightK , RooneyN , FeeneyM , TateJ , RobertsonD , WelhamM , et al. Differential expression of cannabinoid receptors in the human colon: Cannabinoids promote epithelial wound healing. Gastroenterology2005;129(2):437‐53. ">Wright 2005</a>). There is also evidence that upregulation of CB1 receptors and activation of CB1 receptors physiologically protects the colon during excessive inflammation in the colon (<a href="./references#CD012853-bbs2-0029" title="MassaF , MarsicanoG , HermannH , CannichA , MonoryK , CravattB , et al. The endogenous cannabinoid system protects against colonic inflammation. Journal of Clinical Investigation2004;113(8):1202‐9. ">Massa 2004</a>). </p> <p>CB2 receptors are mainly expressed in immune cells, myenteric plexus neurons, and in epithelial cells during ulcerative colitis (<a href="./references#CD012853-bbs2-0016" title="HasenoehrlC , TaschlerU , StorrM , SchichoR . The gastrointestinal tract – a central organ of cannabinoid signaling in health and disease. Journal of Neurogastroenterology and Motility2016;28(12):1765‐80. ">Hasenoehrl 2016</a>; <a href="./references#CD012853-bbs2-0024" title="KleinTW , CarbralGA . Cannabinoid‐Induced immune suppression and modulation of antigen‐presenting cells. Journal of Neuroimmune Pharmacology2006;1:50‐64. ">Klein 2006</a>; <a href="./references#CD012853-bbs2-0028" title="MarquezL , SuarezJ , IglesiasM , Bermudez‐SilvaFJ , Rodriguez deFonsecaF , AndreuM . Ulcerative colitis induces changes on the expression of the endocannabinoid system in the human colonic tissue. PLoS ONE2009;4(9):e6893. ">Marquez 2009</a>). CB2 receptors are expressed on immune cells such B‐cells, NK cells and macrophages (<a href="./references#CD012853-bbs2-0024" title="KleinTW , CarbralGA . Cannabinoid‐Induced immune suppression and modulation of antigen‐presenting cells. Journal of Neuroimmune Pharmacology2006;1:50‐64. ">Klein 2006</a>). CB2 activation leads to T‐cell apoptosis and decreased proliferation in colitis (<a href="./references#CD012853-bbs2-0036" title="SinghUP , SinghNP , SinghB , PriceRL , NagarkattiM , NagarkattiPS . Cannabinoids Receptor‐2 (CB2) agonist ameliorates colitis inIL‐10−/− mice by attenuating the activation of T cells and promoting their apoptosis. Toxicology and Applied Pharmacology2012;258(2):256–67. ">Singh 2012</a>). CB2 activation also decreases the recruitment of neutrophils, T cells and macrophages to the inflamed colon (<a href="./references#CD012853-bbs2-0036" title="SinghUP , SinghNP , SinghB , PriceRL , NagarkattiM , NagarkattiPS . Cannabinoids Receptor‐2 (CB2) agonist ameliorates colitis inIL‐10−/− mice by attenuating the activation of T cells and promoting their apoptosis. Toxicology and Applied Pharmacology2012;258(2):256–67. ">Singh 2012</a>). </p> <p>Other receptors in the GI tract have been found to be endocannabinoid‐responsive through mechanisms separate from CB1 and CB2 receptors (<a href="./references#CD012853-bbs2-0016" title="HasenoehrlC , TaschlerU , StorrM , SchichoR . The gastrointestinal tract – a central organ of cannabinoid signaling in health and disease. Journal of Neurogastroenterology and Motility2016;28(12):1765‐80. ">Hasenoehrl 2016</a>). These include the peroxisome proliferator‐activated receptor alpha, the G‐protein coupled receptor 55, and transient receptor potential cation channel subfamily V member 1 (<a href="./references#CD012853-bbs2-0016" title="HasenoehrlC , TaschlerU , StorrM , SchichoR . The gastrointestinal tract – a central organ of cannabinoid signaling in health and disease. Journal of Neurogastroenterology and Motility2016;28(12):1765‐80. ">Hasenoehrl 2016</a>). Cannabinoids also help modulate chemokine and cytokine release (<a href="./references#CD012853-bbs2-0024" title="KleinTW , CarbralGA . Cannabinoid‐Induced immune suppression and modulation of antigen‐presenting cells. Journal of Neuroimmune Pharmacology2006;1:50‐64. ">Klein 2006</a>). </p> </section> <section id="CD012853-sec-0027"> <h3 class="title" id="CD012853-sec-0027">Why it is important to do this review</h3> <p>This review was undertaken to evaluate the strength of evidence for the use of cannabis and cannabinoids as treatment for CD. It will help clarify if this therapy leads to objective physiological improvement beyond subjective and psychotropic scores. Further, we hope to evaluate various modes of consumption and assess for adverse effects. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD012853-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD012853-sec-0028"></div> <p>The primary objective was to assess the efficacy and safety of cannabis for induction and maintenance of remission in people with Crohn’s disease. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD012853-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD012853-sec-0029"></div> <section id="CD012853-sec-0030"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD012853-sec-0031"> <h4 class="title">Types of studies</h4> <p>Randomized controlled intervention trials were considered for inclusion. Studies published as abstracts were only included if the authors could be reached for further information to allow for evaluation of quality and main outcomes. </p> </section> <section id="CD012853-sec-0032"> <h4 class="title">Types of participants</h4> <p>Adults (&gt; 18 years of age) with Crohn’s disease (as defined by the included studies) were considered for inclusion. Clinical remission or quiescent disease was defined by the Crohn's Disease Activity Index (CDAI). Participants with active (e.g. CDAI &gt; 150) or quiescent disease (defined as mild or absent symptoms prior to entering the study or by a CDAI &lt; 150) were included. People with surgically‐induced remission were excluded. </p> </section> <section id="CD012853-sec-0033"> <h4 class="title">Types of interventions</h4> <p>Studies comparing any form of cannabis or its cannabinoid derivatives (natural or synthetic) to placebo or an active therapy for Crohn’s disease were included. We also included studies that assessed different cannabis or cannabinoid doses. An attempt was made to analyze dose response if data were available. </p> </section> <section id="CD012853-sec-0034"> <h4 class="title">Types of outcome measures</h4> <section id="CD012853-sec-0035"> <h5 class="title">Primary outcomes</h5> <p>The primary outcome was remission at study endpoint for induction of remission studies (as defined by a CDAI &lt; 150) and relapse (e.g. CDAI &gt; 150) at study endpoint for maintenance studies. Any validated scoring system such as the CDAI or Disease Activity Score (DAS) was included. </p> </section> <section id="CD012853-sec-0036"> <h5 class="title">Secondary outcomes</h5> <p>Secondary outcomes included:</p> <p>1. Clinical response;</p> <p>2. Endoscopic remission;</p> <p>3. Endoscopic improvement;</p> <p>4. Histological response;</p> <p>5. Quality of life;</p> <p>6. CRP and fecal calprotectin measurements;</p> <p>7. Adverse events;</p> <p>8. Serious adverse events;</p> <p>9. Withdrawal due to adverse events; and</p> <p>10. Cannabis dependence and withdrawal effects.</p> </section> </section> </section> <section id="CD012853-sec-0037"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD012853-sec-0038"> <h4 class="title">Electronic searches</h4> <p>We searched the following databases from inception up to 17 October 2018: MEDLINE, Embase, AMED (Allied &amp; Alternative Medicine), PsychINFO, the Cochrane IBD Group Specialized Register, CENTRAL, ClinicalTrials.Gov, and the European Clinical Trials Register. </p> <p>We searched abstracts from major gastroenterological meetings to identify research published in abstract form. We also contacted authors in this field for upcoming publications. The electronic search strategy is reported in <a href="./appendices#CD012853-sec-0076">Appendix 1</a>. </p> </section> <section id="CD012853-sec-0039"> <h4 class="title">Searching other resources</h4> <p>Conference proceedings were searched to identify studies published in abstract form. We also searched the references of applicable studies and systematic reviews to identify additional studies. We searched ClinicalTrials.gov and the EU Clinical Trials Register to identify ongoing studies. </p> </section> </section> <section id="CD012853-sec-0040"> <h3 class="title" id="CD012853-sec-0040">Data collection and analysis</h3> <section id="CD012853-sec-0041"> <h4 class="title">Selection of studies</h4> <p>Study papers and abstracts were identified by the literature search and reviewed. Two authors (TK and NC) independently screened the search results to identify potentially relevant studies for full text evaluation. The studies selected for full text review were independently assessed by two authors (TK and NC) and consensus for study inclusion and exclusion was reached through discussion. Any conflicts regarding inclusion or exclusion were resolved through discussion and by consultation with a third author (JKM) as necessary. Studies published in abstract form were only be included if the authors could be reached for further information. </p> </section> <section id="CD012853-sec-0042"> <h4 class="title">Data extraction and management</h4> <p>Two authors (TK and NC) independently extracted the outcome data of interest from each study. Any conflicts were resolved by discussion and consensus or by consultation with a third author (JKM) as necessary. If data were missing or unclear, the study authors were contacted for clarification. </p> <p>Other information extracted from the studies included:</p> <p>a. Study characteristics and design;</p> <p>b. Characteristics of participants;</p> <p>c. Inclusion and exclusion criteria;</p> <p>d. Interventions; and</p> <p>e. Outcomes scoring methods.</p> </section> <section id="CD012853-sec-0043"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two authors (TK and NC) independently assessed the methodological quality of included studies using the Cochrane risk of bias tool (<a href="./references#CD012853-bbs2-0018" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: HigginsJPT , GreenS editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011a</a>). Any conflicts were resolved by discussion and consensus or by consultation with a third author (JKM) as necessary. Items assessed included:<br/> <br/> 1. Random sequence generation; </p> <p>2. Allocation sequence concealment;</p> <p>3. Blinding of participants, personnel and assessment of outcome;</p> <p>4. Incomplete outcome data;</p> <p>5. Selective outcome reporting; and</p> <p>6. Other potential sources of bias.</p> <p>Each category was evaluated as low, high or unclear risk. Judgment justification was provided in the Characteristics of included studies section of the review. </p> <p><b>GRADE Analysis</b> </p> <p>The overall quality of the evidence supporting the primary outcome and selected secondary outcomes was evaluated using the GRADE criteria (<a href="./references#CD012853-bbs2-0014" title="GuyattGH , OxmanAD , VistGE , KunzR , Falck‐YtterY , Alonso‐CoelloP , et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ2008;336(7650):924–6. ">Guyatt 2008</a>; <a href="./references#CD012853-bbs2-0035" title="SchünemannHJ , OxmanAD , VistGE , HigginsJPT , DeeksJJ , GlasziouP , et al. Chapter 12: Interpreting results and drawing conclusions. In: HigginsJPT , GreenS editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Schünemann 2011</a>). Using this approach, outcome data were rated high, moderate, low or very low certainty. Outcome data from randomized controlled trials begins as high certainty, but could be downgraded based on several criteria. These criteria included: </p> <p>1. Risk of bias from the studies;</p> <p>2. Indirect evidence (by comparison, population, setting);</p> <p>3. Inconsistency (i.e. unexplained heterogeneity);</p> <p>4. Imprecision in data (i.e. few events and wide confidence intervals); and</p> <p>5. Likelihood of publication bias.</p> </section> <section id="CD012853-sec-0044"> <h4 class="title">Measures of treatment effect</h4> <p>For dichotomous outcomes, we calculated the risk ratio (RR) and corresponding 95% confidence interval (CI). For continuous outcomes, we calculated the mean difference (MD) and corresponding 95% CI . </p> </section> <section id="CD012853-sec-0045"> <h4 class="title">Unit of analysis issues</h4> <p>For multi‐arm trials with a single placebo group and two treatment dose groups, we planned to split the placebo group in half to avoid a unit of analysis error (<a href="./references#CD012853-bbs2-0019" title="HigginsJPT , DeeksJJ , Altman DG(editors) . Chapter 16: Special topics in statistics. In: HigginsJPT , GreenS editor(s). Cochrane Handbook for Systematic Reviewsof Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011b</a>). To avoid potential carry‐over effects, we planned to only include the first part of the study (i.e. before the cross‐over) for any cross‐over studies (<a href="./references#CD012853-bbs2-0019" title="HigginsJPT , DeeksJJ , Altman DG(editors) . Chapter 16: Special topics in statistics. In: HigginsJPT , GreenS editor(s). Cochrane Handbook for Systematic Reviewsof Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011b</a>). </p> <p>For studies where events reoccurred, we included the proportion of participants who experienced at least one event (i.e. the first event). When there were repeated observations on participants, we used the primary endpoint defined by the study. We did not find study designs applicable to cannabis in Crohn’s disease where multiple treatment attempts were used. We did not find any available cluster‐randomized studies. </p> </section> <section id="CD012853-sec-0046"> <h4 class="title">Dealing with missing data</h4> <p>Data were analyzed on an intention‐to‐treat basis. Studies were evaluated for missing data and where explanations were not provided, the patient outcome was considered to be a treatment failure. For dichotomous outcomes, we dealt with missing data by treating missing participants as treatment failures. We counted failures as a relapse for maintenance studies and as failure to enter remission for induction studies. </p> <p>We conducted an available case analysis for missing continuous outcomes. For missing standard deviations of continuous outcomes, we imputed standard deviations where reasonably possible. Sensitivity analysis was used to assess the impact of any imputation. </p> </section> <section id="CD012853-sec-0047"> <h4 class="title">Assessment of heterogeneity</h4> <p>We planned to assess statistical heterogeneity using the Chi<sup>2</sup> test and I<sup>2</sup> statistic. For the Chi<sup>2</sup> test, a P value of less than 0.1 would be considered statistically significant. We planned to use the I<sup>2</sup> statistic to assess the degree of statistical heterogeneity. We planned to investigate heterogeneity by visually inspecting the forest plots to identify outliers. If outliers were identified, we would conduct sensitivity analysis to explore potential explanations for the heterogeneity. If significant heterogeneity was identified, a random‐effects model would be used. We planned to not pool data for meta‐analysis when a high degree of heterogeneity was detected (e.g. I<sup>2</sup> &gt; 75%). </p> </section> <section id="CD012853-sec-0048"> <h4 class="title">Assessment of reporting biases</h4> <p>We assessed selective reporting by comparing outcomes pre‐specified in study protocols to those reported in study manuscripts. If protocols were not available for the included studies, we assessed reporting bias by comparing the outcomes specified in the methods section of the manuscript to those reported in the results section. If there were more than 10 included studies in a pooled analysis, we planned to investigated publication bias by constructing funnel plots (<a href="./references#CD012853-bbs2-0009" title="EggerM , Davey SmithG , SchneiderM , MinderC . Bias in meta‐analysis detected by a simple, graphical test. BMJ1997;315:629‐34. ">Egger 1997</a>). </p> </section> <section id="CD012853-sec-0049"> <h4 class="title">Data synthesis</h4> <p>We planned to combine data from individual trials when the interventions, patient groups and outcomes were sufficiently similar (determined by consensus). When pooling studies was not possible, we narratively summarized the results of individual trials. For dichotomous outcomes, we planned to calculate the pooled RR and 95% CI using a fixed‐effect model. For continuous outcomes, we planned to calculate the pooled MD and corresponding 95% CI. For continuous outcomes that utilized different scales to measure the same underlying construct, we planned to calculate the standardized mean difference (SMD) and corresponding 95% CI. </p> </section> <section id="CD012853-sec-0050"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We attempted to perform subgroup analyses by dose and formula (e.g. based on dose of THC, dose of cannabidiol , or combination formula) when the data allowed for such comparisons. Other subgroup analyses considered included an effect based on disease location, cigarette smoking status, history of biologic therapy and failure of biologic therapy. </p> </section> <section id="CD012853-sec-0051"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to perform a sensitivity analysis based on risk of bias. However, there were no studies were pooled for analysis because of differences in the interventions. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD012853-sec-0052" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD012853-sec-0052"></div> <section id="CD012853-sec-0053"> <h3 class="title">Description of studies</h3> <section id="CD012853-sec-0054"> <h4 class="title">Results of the search</h4> <p>A literature search conducted on 17 October 2018 identified 91 studies. After duplicates were removed, a total of 63 studies remained for screening. Fifty‐six of these studies were not applicable. Seven studies remained for full‐text review. One study was excluded (<a href="./references#CD012853-bbs2-0004" title="NaftaliT , BarlevL , GabayG , ChowersY , DotanI , SteinA , et al. Tetrahydrocannabinol (THC) induces clinical and biochemical improvement with a steroid sparing effect in active inflammatory bowel disease. Journal of Crohn's and Colitis2013;7(Supplement1):S153. ">Naftali 2013b</a>). Five reports of three studies (93 participants) met the inclusion criteria and were included in the review (See <a href="#CD012853-fig-0001">Figure 1</a>). One ongoing study was also identified (<a href="./references#CD012853-bbs2-0005" title="NCT03467620 . Cannabidiol Usage as an Adjunct Therapy for Crohn's Disease [Oral Cannabidiol Capsule Usage as an Adjunct Therapy for Crohn's Disease: a Randomized, Placebo‐controlled Study]. clinicaltrials.gov/ct2/show/NCT03467620 (accessed 17 October 2018). ">NCT03467620</a>). </p> <div class="figure" id="CD012853-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Flow diagram." data-id="CD012853-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/image_n/nCD012853-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Flow diagram.</p> </div> </div> </div> </section> <section id="CD012853-sec-0055"> <h4 class="title">Included studies</h4> <p><a href="./references#CD012853-bbs2-0001" title="NaftaliT , Bar‐LevL , GabayG , ChowersY , DotanI , BronshteinM , et al. Tetrahydrocannabinol (THC) rich medical cannabis induces clinical and biochemical improvement with a steroid sparing effect in active Crohn's disease. Gastroenterology2012;1:S780. NaftaliT , Bar‐Lev SchleiderL , DotanI , LanskyEP , Sklerovsky BenjaminovF , KonikoffFM . Cannabis induces a clinical response in patients with Crohn’s disease: a prospective placebo‐controlled study. Clinical Gastroenterology and Hepatology2013;11(10):1276‐80. ">Naftali 2013a</a> was a randomized, single‐centre, double‐blind, placebo‐controlled trial. The purpose of the study was to determine whether cannabis can induce remission in participants with active Crohn’s disease. Participants were given either cannabis cigarettes containing 115 mg of THC twice daily or placebo cigarettes composed of cannabis flowers from which the THC had been extracted. Participants were treated for eight weeks. Twenty‐two people were randomized, but 21 participants were studied (cannabis n = 11; placebo n = 10). One person declined participation after signing consent, but before receiving any study drugs. Inclusion criteria were an established diagnosis of Crohn’s disease, at least 20 years of age, and active Crohn’s disease (with a calculated CDAI score between 200 and 450 points) at study entry. All participants had failed at least one form of medical treatment for the disease including mesalamine, corticosteroids, thiopurines, methotrexate, or anti–TNF‐α. Anti–TNF‐α failure was declared after at least four doses. Participants receiving corticosteroids had to be receiving a stable dose for at least one month prior to study entry, and participants receiving thiopurines had to be receiving a stable dose for at least three months prior to entry. Participants were followed at weeks 0, 2, 8, and 10 (2 weeks after treatment done). The primary outcome was induction of remission, defined as a CDAI score of 150 or less after 8 weeks of cannabis treatment. Secondary outcomes included response rate, defined as a 100‐point reduction of CDAI from baseline, a reduction of at least 0.5 mg in C‐reactive protein (CRP), or improvement in quality of life of at least 50 points, as measured by the Short‐Form 36 (SF‐36) health survey. Adverse effects were assessed by questionnaire and severity was assessed on a scale from one to seven, with one meaning no symptoms and seven corresponding with severe symptoms. </p> <p><a href="./references#CD012853-bbs2-0002" title="NaftaliT , MechoulamR , GabayG , SteinA , BronshteinM , MariA , et al. Cannabidiol treatment does not effect active Crohn's disease. Gastroenterology2013;1:S180. NaftaliT , MechulamR , MariiA , GabayG , SteinA , BronshtainM , et al. Low‐dose cannabidiol is safe but not effective in the treatment for Crohn’s Disease, a randomized controlled trial. Digestive Diseases and Sciences2017;62:1615–20. ">Naftali 2017a</a> was a randomized, single‐centre, double‐blind, placebo‐controlled trial. The purpose of the study was to assess the effects of cannabidiol in participants with active Crohn’s disease. Participants were given either 2 ml twice daily of cannabis oil at a concentration of 5 mg/ml (i.e. 20 mg/day or approximately 5% cannabidiol) or placebo containing pure olive oil 2 ml twice daily. Twenty‐one participants were recruited, one withdrew consent before any consumption of the study drug and one was withdrawn due to colitis. Nineteen participants completed the study. Participants were at least 20 years of age, had active Crohn’s disease with a calculated CDAI score between 200 and 450 points, and received at least one form of medical treatment for Crohn’s disease with no effect. Previous treatments included mesalamine, corticosteroids, thiopurines, methotrexate, or anti‐TNF‐α. Participants receiving corticosteroids had to be on a stable dose for at least one month. Participants receiving thiopurines had to be on a stable dose for at least three months, and participants receiving anti‐TNF‐α had received at least four infusions before failure was declared. Participants were visited at weeks 0, 2, 8, and 10. The primary outcome was a reduction of 70 points in CDAI from week 0 to week 8. Secondary outcomes included any adverse events within the time frame of eight weeks, ability to stop steroids in participants who were treated with steroids at the beginning of the study, and reduction in at least 1 mg/dl in the CRP level. Adverse effects were assessed by questionnaire as described for <a href="./references#CD012853-bbs2-0001" title="NaftaliT , Bar‐LevL , GabayG , ChowersY , DotanI , BronshteinM , et al. Tetrahydrocannabinol (THC) rich medical cannabis induces clinical and biochemical improvement with a steroid sparing effect in active Crohn's disease. Gastroenterology2012;1:S780. NaftaliT , Bar‐Lev SchleiderL , DotanI , LanskyEP , Sklerovsky BenjaminovF , KonikoffFM . Cannabis induces a clinical response in patients with Crohn’s disease: a prospective placebo‐controlled study. Clinical Gastroenterology and Hepatology2013;11(10):1276‐80. ">Naftali 2013a</a> </p> <p><a href="./references#CD012853-bbs2-0003" title="NaftaliT , SchliederLBL , KonikoffFM . The effect of cannabis on Crohn's Disease patients. International Association of Cannabis Medicine (IACM). 2017. ">Naftali 2017b</a> was an abstract presented at the International Association of Cannabis Medicine in September 2017. This study was sent to us by the first author. It is a randomized, double‐blind, placebo‐controlled trial looking at the effect of cannabis on Crohn's disease. Participants were randomized to either cannabis oil (15% cannabidiol and 4% THC) or placebo oil for eight weeks of treatment. The cannabis oil group had 24 participants and the placebo oil group had 26 participants. Inclusion criteria were not specified. Outcomes included the CDAI, inflammatory markers and quality of life as measured by the Short‐Form 36 (SF‐36) health survey. These outcomes were assessed before, during and after treatment. </p> </section> <section id="CD012853-sec-0056"> <h4 class="title">Excluded studies</h4> <p><a href="./references#CD012853-bbs2-0004" title="NaftaliT , BarlevL , GabayG , ChowersY , DotanI , SteinA , et al. Tetrahydrocannabinol (THC) induces clinical and biochemical improvement with a steroid sparing effect in active inflammatory bowel disease. Journal of Crohn's and Colitis2013;7(Supplement1):S153. ">Naftali 2013b</a> was excluded because we were not able to acquire separate data for participants with Crohn's disease and ulcerative colitis. The study included 10 people with ulcerative colitis and 22 people with Crohn's disease. </p> </section> </section> <section id="CD012853-sec-0057"> <h3 class="title">Risk of bias in included studies</h3> <p>Bias was assessed using the Cochrane risk of bias tool. The risk of bias results are summarized in <a href="#CD012853-fig-0002">Figure 2</a>. </p> <div class="figure" id="CD012853-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012853-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/image_n/nCD012853-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD012853-sec-0058"> <h4 class="title">Allocation</h4> <p>Random sequence generation was rated as low risk of bias for all three studies given the use of the block randomization. </p> <p>Allocation concealment was rated as unclear risk of bias for <a href="./references#CD012853-bbs2-0001" title="NaftaliT , Bar‐LevL , GabayG , ChowersY , DotanI , BronshteinM , et al. Tetrahydrocannabinol (THC) rich medical cannabis induces clinical and biochemical improvement with a steroid sparing effect in active Crohn's disease. Gastroenterology2012;1:S780. NaftaliT , Bar‐Lev SchleiderL , DotanI , LanskyEP , Sklerovsky BenjaminovF , KonikoffFM . Cannabis induces a clinical response in patients with Crohn’s disease: a prospective placebo‐controlled study. Clinical Gastroenterology and Hepatology2013;11(10):1276‐80. ">Naftali 2013a</a> as the methods for allocation concealment were not described. <a href="./references#CD012853-bbs2-0002" title="NaftaliT , MechoulamR , GabayG , SteinA , BronshteinM , MariA , et al. Cannabidiol treatment does not effect active Crohn's disease. Gastroenterology2013;1:S180. NaftaliT , MechulamR , MariiA , GabayG , SteinA , BronshtainM , et al. Low‐dose cannabidiol is safe but not effective in the treatment for Crohn’s Disease, a randomized controlled trial. Digestive Diseases and Sciences2017;62:1615–20. ">Naftali 2017a</a> and <a href="./references#CD012853-bbs2-0003" title="NaftaliT , SchliederLBL , KonikoffFM . The effect of cannabis on Crohn's Disease patients. International Association of Cannabis Medicine (IACM). 2017. ">Naftali 2017b</a> were rated as low risk of bias for allocation concealment. Both studies used sequentially numbered drug containers of identical appearance. . </p> </section> <section id="CD012853-sec-0059"> <h4 class="title">Blinding</h4> <p>Blinding was performed for both participants and investigators in all three studies. Both <a href="./references#CD012853-bbs2-0002" title="NaftaliT , MechoulamR , GabayG , SteinA , BronshteinM , MariA , et al. Cannabidiol treatment does not effect active Crohn's disease. Gastroenterology2013;1:S180. NaftaliT , MechulamR , MariiA , GabayG , SteinA , BronshtainM , et al. Low‐dose cannabidiol is safe but not effective in the treatment for Crohn’s Disease, a randomized controlled trial. Digestive Diseases and Sciences2017;62:1615–20. ">Naftali 2017a</a> and <a href="./references#CD012853-bbs2-0003" title="NaftaliT , SchliederLBL , KonikoffFM . The effect of cannabis on Crohn's Disease patients. International Association of Cannabis Medicine (IACM). 2017. ">Naftali 2017b</a> used identical placebos and were rated as low risk of bias. However, blinding was not effective in <a href="./references#CD012853-bbs2-0001" title="NaftaliT , Bar‐LevL , GabayG , ChowersY , DotanI , BronshteinM , et al. Tetrahydrocannabinol (THC) rich medical cannabis induces clinical and biochemical improvement with a steroid sparing effect in active Crohn's disease. Gastroenterology2012;1:S780. NaftaliT , Bar‐Lev SchleiderL , DotanI , LanskyEP , Sklerovsky BenjaminovF , KonikoffFM . Cannabis induces a clinical response in patients with Crohn’s disease: a prospective placebo‐controlled study. Clinical Gastroenterology and Hepatology2013;11(10):1276‐80. ">Naftali 2013a</a> due to the psychotropic effects of cannabis. Almost all participants were aware of their study allocation with the exception of two participants in the placebo group, before the end of the study. As a result we decided to rate <a href="./references#CD012853-bbs2-0001" title="NaftaliT , Bar‐LevL , GabayG , ChowersY , DotanI , BronshteinM , et al. Tetrahydrocannabinol (THC) rich medical cannabis induces clinical and biochemical improvement with a steroid sparing effect in active Crohn's disease. Gastroenterology2012;1:S780. NaftaliT , Bar‐Lev SchleiderL , DotanI , LanskyEP , Sklerovsky BenjaminovF , KonikoffFM . Cannabis induces a clinical response in patients with Crohn’s disease: a prospective placebo‐controlled study. Clinical Gastroenterology and Hepatology2013;11(10):1276‐80. ">Naftali 2013a</a> as high risk of bias for blinding of participants. Outcome assessors were blinded in all three studies and this item was rated as low risk of bias. </p> </section> <section id="CD012853-sec-0060"> <h4 class="title">Incomplete outcome data</h4> <p>Incomplete outcome data were rated as unclear for <a href="./references#CD012853-bbs2-0001" title="NaftaliT , Bar‐LevL , GabayG , ChowersY , DotanI , BronshteinM , et al. Tetrahydrocannabinol (THC) rich medical cannabis induces clinical and biochemical improvement with a steroid sparing effect in active Crohn's disease. Gastroenterology2012;1:S780. NaftaliT , Bar‐Lev SchleiderL , DotanI , LanskyEP , Sklerovsky BenjaminovF , KonikoffFM . Cannabis induces a clinical response in patients with Crohn’s disease: a prospective placebo‐controlled study. Clinical Gastroenterology and Hepatology2013;11(10):1276‐80. ">Naftali 2013a</a> and low risk of bias for <a href="./references#CD012853-bbs2-0002" title="NaftaliT , MechoulamR , GabayG , SteinA , BronshteinM , MariA , et al. Cannabidiol treatment does not effect active Crohn's disease. Gastroenterology2013;1:S180. NaftaliT , MechulamR , MariiA , GabayG , SteinA , BronshtainM , et al. Low‐dose cannabidiol is safe but not effective in the treatment for Crohn’s Disease, a randomized controlled trial. Digestive Diseases and Sciences2017;62:1615–20. ">Naftali 2017a</a> and . <a href="./references#CD012853-bbs2-0003" title="NaftaliT , SchliederLBL , KonikoffFM . The effect of cannabis on Crohn's Disease patients. International Association of Cannabis Medicine (IACM). 2017. ">Naftali 2017b</a>. There was a higher drop out rate in the placebo group of the <a href="./references#CD012853-bbs2-0001" title="NaftaliT , Bar‐LevL , GabayG , ChowersY , DotanI , BronshteinM , et al. Tetrahydrocannabinol (THC) rich medical cannabis induces clinical and biochemical improvement with a steroid sparing effect in active Crohn's disease. Gastroenterology2012;1:S780. NaftaliT , Bar‐Lev SchleiderL , DotanI , LanskyEP , Sklerovsky BenjaminovF , KonikoffFM . Cannabis induces a clinical response in patients with Crohn’s disease: a prospective placebo‐controlled study. Clinical Gastroenterology and Hepatology2013;11(10):1276‐80. ">Naftali 2013a</a> study compared to the cannabis group (three placebo versus one cannabis). Alternatively, there were no drop outs for the <a href="./references#CD012853-bbs2-0002" title="NaftaliT , MechoulamR , GabayG , SteinA , BronshteinM , MariA , et al. Cannabidiol treatment does not effect active Crohn's disease. Gastroenterology2013;1:S180. NaftaliT , MechulamR , MariiA , GabayG , SteinA , BronshtainM , et al. Low‐dose cannabidiol is safe but not effective in the treatment for Crohn’s Disease, a randomized controlled trial. Digestive Diseases and Sciences2017;62:1615–20. ">Naftali 2017a</a> and <a href="./references#CD012853-bbs2-0003" title="NaftaliT , SchliederLBL , KonikoffFM . The effect of cannabis on Crohn's Disease patients. International Association of Cannabis Medicine (IACM). 2017. ">Naftali 2017b</a> studies and therefore, incomplete outcome data was rated as low risk of bias. </p> </section> <section id="CD012853-sec-0061"> <h4 class="title">Selective reporting</h4> <p>All three studies were rated as unclear risk of bias for selective reporting. The protocol for the <a href="./references#CD012853-bbs2-0001" title="NaftaliT , Bar‐LevL , GabayG , ChowersY , DotanI , BronshteinM , et al. Tetrahydrocannabinol (THC) rich medical cannabis induces clinical and biochemical improvement with a steroid sparing effect in active Crohn's disease. Gastroenterology2012;1:S780. NaftaliT , Bar‐Lev SchleiderL , DotanI , LanskyEP , Sklerovsky BenjaminovF , KonikoffFM . Cannabis induces a clinical response in patients with Crohn’s disease: a prospective placebo‐controlled study. Clinical Gastroenterology and Hepatology2013;11(10):1276‐80. ">Naftali 2013a</a> study pre‐specified the primary outcome as clinical response (reduction in CDAI of 70‐points from baseline). In the manuscript the authors reported on clinical remission (CDAI &lt; 150) as the primary outcome. We note that clinical remission is a more stringent outcome than clinical response and that this is not strong evidence of selective reporting to bias the results in favour of the intervention. The study protocol also included change in IL‐10, IL‐2, and TGF beta as secondary outcomes and these outcomes were not reported in the final study manuscript. The protocol for the <a href="./references#CD012853-bbs2-0002" title="NaftaliT , MechoulamR , GabayG , SteinA , BronshteinM , MariA , et al. Cannabidiol treatment does not effect active Crohn's disease. Gastroenterology2013;1:S180. NaftaliT , MechulamR , MariiA , GabayG , SteinA , BronshtainM , et al. Low‐dose cannabidiol is safe but not effective in the treatment for Crohn’s Disease, a randomized controlled trial. Digestive Diseases and Sciences2017;62:1615–20. ">Naftali 2017a</a> study also pre‐specified the primary outcome as clinical response (reduction in CDAI of 70‐points from baseline). In the manuscript the authors reported on clinical remission (CDAI &lt; 150) as the primary outcome. Again we note that clinical remission is a more stringent outcome than clinical response and that this is not strong evidence of selective reporting to bias the results in favour of the intervention. The study protocol also included a reduction of at least 1mg/dL in the serum CRP levels and this was not reported in the final manuscript. The <a href="./references#CD012853-bbs2-0003" title="NaftaliT , SchliederLBL , KonikoffFM . The effect of cannabis on Crohn's Disease patients. International Association of Cannabis Medicine (IACM). 2017. ">Naftali 2017b</a> was published as an abstract. The abstract reported on a pre‐specified secondary outcome (quality of life) but did not report on the pre‐specified primary outcome from the study protocol (clinical response defined by a 100‐point reduction in CDAI) or other pre‐specified outcomes (e.g. clinical remission). However, these outcomes could be reported on in the full study manuscript. </p> </section> <section id="CD012853-sec-0062"> <h4 class="title">Other potential sources of bias</h4> <p><a href="./references#CD012853-bbs2-0001" title="NaftaliT , Bar‐LevL , GabayG , ChowersY , DotanI , BronshteinM , et al. Tetrahydrocannabinol (THC) rich medical cannabis induces clinical and biochemical improvement with a steroid sparing effect in active Crohn's disease. Gastroenterology2012;1:S780. NaftaliT , Bar‐Lev SchleiderL , DotanI , LanskyEP , Sklerovsky BenjaminovF , KonikoffFM . Cannabis induces a clinical response in patients with Crohn’s disease: a prospective placebo‐controlled study. Clinical Gastroenterology and Hepatology2013;11(10):1276‐80. ">Naftali 2013a</a> was rated as high risk of bias for other potential sources of bias because participants in the cannabis participants were significantly older than participants in the placebo group. <a href="./references#CD012853-bbs2-0002" title="NaftaliT , MechoulamR , GabayG , SteinA , BronshteinM , MariA , et al. Cannabidiol treatment does not effect active Crohn's disease. Gastroenterology2013;1:S180. NaftaliT , MechulamR , MariiA , GabayG , SteinA , BronshtainM , et al. Low‐dose cannabidiol is safe but not effective in the treatment for Crohn’s Disease, a randomized controlled trial. Digestive Diseases and Sciences2017;62:1615–20. ">Naftali 2017a</a> was rated as high risk of bias because there were significantly more smokers in the cannabis oil group than the placebo group. Sixty per cent of the cannabis oil group smoked compared to none of the placebo group. The <a href="./references#CD012853-bbs2-0003" title="NaftaliT , SchliederLBL , KonikoffFM . The effect of cannabis on Crohn's Disease patients. International Association of Cannabis Medicine (IACM). 2017. ">Naftali 2017b</a> study was rated as low risk of bias.. </p> </section> </section> <section id="CD012853-sec-0063"> <h3 class="title" id="CD012853-sec-0063">Effects of interventions</h3> <p>See: <a href="./full#CD012853-tbl-0001"><b>Summary of findings for the main comparison</b> Cannabis cigarettes (115 mg THC) compared to placebo cigarettes for the treatment of active Crohn's disease</a>; <a href="./full#CD012853-tbl-0002"><b>Summary of findings 2</b> Cannabis oil (5% cannabidiol sublingual oil) compared to placebo oil for the treatment of active Crohn's disease</a>; <a href="./full#CD012853-tbl-0003"><b>Summary of findings 3</b> Cannabis oil (15% cannabidiol and 4% THC) compared to placebo oil for the treatment of active Crohn's disease</a> </p> <p>Data from the three included studies were not pooled due to the different routes of administration and formula composition for the two studies that used cannabis oil. The <a href="./references#CD012853-bbs2-0001" title="NaftaliT , Bar‐LevL , GabayG , ChowersY , DotanI , BronshteinM , et al. Tetrahydrocannabinol (THC) rich medical cannabis induces clinical and biochemical improvement with a steroid sparing effect in active Crohn's disease. Gastroenterology2012;1:S780. NaftaliT , Bar‐Lev SchleiderL , DotanI , LanskyEP , Sklerovsky BenjaminovF , KonikoffFM . Cannabis induces a clinical response in patients with Crohn’s disease: a prospective placebo‐controlled study. Clinical Gastroenterology and Hepatology2013;11(10):1276‐80. ">Naftali 2013a</a> study participants took 115 mg of THC in the form of cigarettes (twice daily) and the <a href="./references#CD012853-bbs2-0002" title="NaftaliT , MechoulamR , GabayG , SteinA , BronshteinM , MariA , et al. Cannabidiol treatment does not effect active Crohn's disease. Gastroenterology2013;1:S180. NaftaliT , MechulamR , MariiA , GabayG , SteinA , BronshtainM , et al. Low‐dose cannabidiol is safe but not effective in the treatment for Crohn’s Disease, a randomized controlled trial. Digestive Diseases and Sciences2017;62:1615–20. ">Naftali 2017a</a> study participants took cannabis oil at a concentration of 5% cannabidiol. The <a href="./references#CD012853-bbs2-0003" title="NaftaliT , SchliederLBL , KonikoffFM . The effect of cannabis on Crohn's Disease patients. International Association of Cannabis Medicine (IACM). 2017. ">Naftali 2017b</a> study utilized cannabis oil at a concentration of 15% cannabidiol and 4% THC. </p> <p><b>Cannabis cigarettes (115 mg THC) versus placebo cigarettes at 8 weeks:</b> </p> <p>Clinical remission rates at eight weeks were higher in the cannabis cigarettes group compared to placebo cigarettes (<a href="./references#CD012853-bbs2-0001" title="NaftaliT , Bar‐LevL , GabayG , ChowersY , DotanI , BronshteinM , et al. Tetrahydrocannabinol (THC) rich medical cannabis induces clinical and biochemical improvement with a steroid sparing effect in active Crohn's disease. Gastroenterology2012;1:S780. NaftaliT , Bar‐Lev SchleiderL , DotanI , LanskyEP , Sklerovsky BenjaminovF , KonikoffFM . Cannabis induces a clinical response in patients with Crohn’s disease: a prospective placebo‐controlled study. Clinical Gastroenterology and Hepatology2013;11(10):1276‐80. ">Naftali 2013a</a>). Clinical remission was reported in 45.5% (5/11) of participants in the treatment group compared to 10% (1/10) of participants in the placebo group (RR 4.55, 95% CI 0.63 to 32.56; very low certainty evidence). Clinical response was reported in 90.9% (10/11) of participants in the treatment group compared to 40% (4/10) of participants in the placebo group (RR 2.27, 95% CI 1.04 to 4.97; very low certainty evidence). There was no difference in serum CRP levels measured at the end of the study. A decrease in CRP of more than 0.5mg/dL from week 0 to week 8 was found in 27% (3/11) of participants in the treatment group compared to 20% (2/10) of participants in the placebo group (RR 1.36, 95% CI 0.28 to 6.56; low certainty evidence). There was an increase in the quality of life scores in the treatment group compared to the placebo group. There was an increase of 28 points in the treatment group from baseline to week 8, compared to a difference of 5 points in the placebo group from baseline to week 8. None of the participants experienced difficulty or withdrawal symptoms when they stopped the cannabis treatment after eight weeks. We acquired the prevalence of adverse effects from the author, and the cannabis group had more adverse events compared to the placebo. Eighty‐two per cent (9/11) of participants in the cannabis group had an adverse event compared to 20% (2/10) of placebo participants (RR 4.09, 95% CI 1.15 to 14.57; very low certainty evidence). However, these adverse events were considered to be mild in nature and included sleepiness, nausea, difficulty with concentration, memory loss, confusion and dizziness. Participants in the cannabis group reported improvements in pain, appetite and satisfaction. Endoscopic remission, endoscopic response, histological response, serious adverse events and withdrawal due to adverse events were not reported in this study. </p> <p><b>Cannabis oil (5% cannabidiol sublingual oil) versus placebo oil at 8 weeks:</b> </p> <p>There was no difference in remission rates at eight weeks in the small study (n = 19) that compared cannabis oil (5% cannabidiol sublingual oil) to placebo oil (<a href="./references#CD012853-bbs2-0002" title="NaftaliT , MechoulamR , GabayG , SteinA , BronshteinM , MariA , et al. Cannabidiol treatment does not effect active Crohn's disease. Gastroenterology2013;1:S180. NaftaliT , MechulamR , MariiA , GabayG , SteinA , BronshtainM , et al. Low‐dose cannabidiol is safe but not effective in the treatment for Crohn’s Disease, a randomized controlled trial. Digestive Diseases and Sciences2017;62:1615–20. ">Naftali 2017a</a>). Clinical remission was reported in 40% (4/10) of participants in the cannabis oil group compared to 33.3% (3/9) of participants in the placebo group (RR 1.20, 95% CI 0.36 to 3.97; very low certainty evidence). There was no difference in the proportion of participants who had a serious adverse event. Ten per cent (1/10) of participants in the cannabis oil group had a serious adverse event compared to 11% (1/9) of placebo participants (RR 0.90, 95% CI 0.07 to 12.38; very low certainty evidence). In both cases the serious adverse event was worsening Crohn's disease that required rescue intervention. The participants did not report any withdrawal symptoms when treatment was stopped. Although the study protocol stated they were going to assess clinical response (reduction of 70 points in the CDAI from week 0 to 8) as the primary outcome, and reduction in CRP level, the final data for these outcomes were not reported. Additionally, endoscopic remission, endoscopic response and histological response were not assessed in this study. Adverse effects were rated on a scale from one to seven and included headache, sleepiness, nausea and dizziness. The authors reported that adverse effects did not differ between the cannabis oil and placebo groups. </p> <p><b>Cannabis oil (15% cannabidiol and 4% THC) versus placebo oil at 8 weeks:</b> </p> <p>The small study (n = 39) comparing cannabis oil (15% cannabidiol and 4% THC) to placebo oil found differences in CDAI scores and quality of life scores as measured by the SF‐36 instrument. The mean quality of life score after 8 weeks of treatment was 96.3 in the cannabis oil group compared to 79.9 in the placebo group (MD 16.40, 95% CI 5.72 to 27.08, low certainty evidence). After 8 weeks of treatment, the mean CDAI score was 118.6 in the cannabis oil group compared to 212.6 in the placebo group (MD ‐94.00, 95%CI ‐148.86 to ‐39.14, low certainty evidence). The abstract did not report on any other outcomes. </p> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD012853-sec-0064" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD012853-sec-0064"></div> <section id="CD012853-sec-0065"> <h3 class="title" id="CD012853-sec-0065">Summary of main results</h3> <p>This systematic review included three small randomized controlled trials (93 participants) that evaluated the efficacy and safety of cannabis and cannabis oil (cannabidiol) in Crohn's disease. Overall, there were sparse data and heterogenous outcomes. Each study used a different dose of cannabis or cannabidiol formula. <a href="./references#CD012853-bbs2-0001" title="NaftaliT , Bar‐LevL , GabayG , ChowersY , DotanI , BronshteinM , et al. Tetrahydrocannabinol (THC) rich medical cannabis induces clinical and biochemical improvement with a steroid sparing effect in active Crohn's disease. Gastroenterology2012;1:S780. NaftaliT , Bar‐Lev SchleiderL , DotanI , LanskyEP , Sklerovsky BenjaminovF , KonikoffFM . Cannabis induces a clinical response in patients with Crohn’s disease: a prospective placebo‐controlled study. Clinical Gastroenterology and Hepatology2013;11(10):1276‐80. ">Naftali 2013a</a> compared cannabis cigarettes (115 mg THC) to placebo cigarettes. <a href="./references#CD012853-bbs2-0002" title="NaftaliT , MechoulamR , GabayG , SteinA , BronshteinM , MariA , et al. Cannabidiol treatment does not effect active Crohn's disease. Gastroenterology2013;1:S180. NaftaliT , MechulamR , MariiA , GabayG , SteinA , BronshtainM , et al. Low‐dose cannabidiol is safe but not effective in the treatment for Crohn’s Disease, a randomized controlled trial. Digestive Diseases and Sciences2017;62:1615–20. ">Naftali 2017a</a> compared cannabis oil composed of 5% cannabidiol sublingual oil to a placebo oil. <a href="./references#CD012853-bbs2-0003" title="NaftaliT , SchliederLBL , KonikoffFM . The effect of cannabis on Crohn's Disease patients. International Association of Cannabis Medicine (IACM). 2017. ">Naftali 2017b</a> compared cannabis oil composed of 15% cannabidiol and 4% THC to a placebo oil. We were only able to extract limited data on quality of life (SF‐36) and CDAI scores from this study. None of the studies were pooled due to the different routes of administration and cannabidiol formulas. No studies were identified that assessed cannabis or cannabis oil therapy in people with quiescent Crohn's disease. </p> <p>In the <a href="./references#CD012853-bbs2-0001" title="NaftaliT , Bar‐LevL , GabayG , ChowersY , DotanI , BronshteinM , et al. Tetrahydrocannabinol (THC) rich medical cannabis induces clinical and biochemical improvement with a steroid sparing effect in active Crohn's disease. Gastroenterology2012;1:S780. NaftaliT , Bar‐Lev SchleiderL , DotanI , LanskyEP , Sklerovsky BenjaminovF , KonikoffFM . Cannabis induces a clinical response in patients with Crohn’s disease: a prospective placebo‐controlled study. Clinical Gastroenterology and Hepatology2013;11(10):1276‐80. ">Naftali 2013a</a> study, clinical remission and response rates were higher in the cannabis cigarette group than the placebo cigarette group at eight weeks. This study found no difference in serum CRP levels after eight weeks of treatment. Participants in the cannabis group were more likely than placebo participants to experience an adverse event. However, these adverse events were considered to be mild in nature and included sleepiness, nausea, difficulty with concentration, memory loss, confusion and dizziness. Participants in the cannabis group reported improvements in pain, appetite and satisfaction with treatment. These results should be interpreted with caution as the GRADE analysis indicated that the overall certainty of the evidence supporting these results was very low due to sparse data and high risk of bias. Thus, we are uncertain about the effects of cannabis cigarettes on Crohn's disease. Further research is needed before any strong conclusions can be drawn on the efficacy and safety of cannabis cigarettes in Crohn's disease. </p> <p>The <a href="./references#CD012853-bbs2-0002" title="NaftaliT , MechoulamR , GabayG , SteinA , BronshteinM , MariA , et al. Cannabidiol treatment does not effect active Crohn's disease. Gastroenterology2013;1:S180. NaftaliT , MechulamR , MariiA , GabayG , SteinA , BronshtainM , et al. Low‐dose cannabidiol is safe but not effective in the treatment for Crohn’s Disease, a randomized controlled trial. Digestive Diseases and Sciences2017;62:1615–20. ">Naftali 2017a</a> study found no difference in clinical remission rates at eight weeks or serious adverse events. One serious adverse event was reported in each group. In both cases the serious adverse event was worsening Crohn's disease that required rescue intervention. Reported adverse events included headache, sleepiness, nausea and dizziness. The GRADE analysis indicated that the overall certainty of the evidence supporting these results was very low due to sparse data and high risk of bias. Thus, we are uncertain about the effects of cannabis oil (5% cannabidiol) on Crohn's disease. Further research is needed before any strong conclusions can be drawn on the efficacy and safety of cannabis oil (5% cannabidiol) in Crohn's disease. </p> <p>Lastly, the <a href="./references#CD012853-bbs2-0003" title="NaftaliT , SchliederLBL , KonikoffFM . The effect of cannabis on Crohn's Disease patients. International Association of Cannabis Medicine (IACM). 2017. ">Naftali 2017b</a> study compared cannabis oil (15% cannabidiol and 4% THC) to placebo. This study was presented as an abstract and only reported on quality of life and CDAI scores. Mean quality of life scores were higher in the cannabis oil group (96.3) compared to placebo (79.9). The mean difference between the cannabis oil and placebo groups was 16.4 points and this is likely to be a clinically meaningful improvement in health‐related quality of life in people with Crohn's disease (<a href="./references#CD012853-bbs2-0021" title="IrvineEJ , FeaganB , RochonJ , ArchambaultA , FedorakRN , GrollA , et al. Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group. Gastroenterology1994;106(2):287‐96. ">Irvine 1994</a>; <a href="./references#CD012853-bbs2-0022" title="IrvineEJ . Quality of life of patients with ulcerative colitis: past, present, and future. Inflammatory Bowel Diseases2008;14(4):554‐65. ">Irvine 2008</a>). However, the GRADE analysis indicated that the overall certainty of the evidence for this outcome was low due to due to serious imprecision. Further research is needed before any firm conclusions can be drawn about potential quality of life benefits with cannabis oil (15% cannabidiol and 4% THC) therapy in Crohn's disease. Mean CDAI scores were lower in cannabis oil participants (118.6) compared to placebo participants (212.6). Although, the difference in CDAI is clinically meaningful (<a href="./references#CD012853-bbs2-0007" title="BrantR , SutherlandL , HilsdenR . Examining the minimum important difference. Statistics in Medicine1999;18(19):2593‐603. ">Brant 1999</a>; <a href="./references#CD012853-bbs2-0010" title="FeaganBG . 5‐ASA therapy for active Crohn's disease: old friends, old data, and a new conclusion. Clinical Gastroenterology and Hepatology2004;2(5):376‐8. ">Feagan 2004</a>), this result should be interpreted with caution given the small number of participants who were assessed. Further research is needed before any firm conclusions can be drawn about potential benefits of cannabis oil in terms of improved disease activity. </p> <p>There are significant risks of bias with the included studies and a paucity of data on adverse events (short‐term and long‐term). The existing studies excluded people with a history of mental illness, drug abuse, or previous cannabis consumption, or if in their physician’s judgement they might be vulnerable to drug addiction or mental instability (<a href="./references#CD012853-bbs2-0001" title="NaftaliT , Bar‐LevL , GabayG , ChowersY , DotanI , BronshteinM , et al. Tetrahydrocannabinol (THC) rich medical cannabis induces clinical and biochemical improvement with a steroid sparing effect in active Crohn's disease. Gastroenterology2012;1:S780. NaftaliT , Bar‐Lev SchleiderL , DotanI , LanskyEP , Sklerovsky BenjaminovF , KonikoffFM . Cannabis induces a clinical response in patients with Crohn’s disease: a prospective placebo‐controlled study. Clinical Gastroenterology and Hepatology2013;11(10):1276‐80. ">Naftali 2013a</a>; <a href="./references#CD012853-bbs2-0002" title="NaftaliT , MechoulamR , GabayG , SteinA , BronshteinM , MariA , et al. Cannabidiol treatment does not effect active Crohn's disease. Gastroenterology2013;1:S180. NaftaliT , MechulamR , MariiA , GabayG , SteinA , BronshtainM , et al. Low‐dose cannabidiol is safe but not effective in the treatment for Crohn’s Disease, a randomized controlled trial. Digestive Diseases and Sciences2017;62:1615–20. ">Naftali 2017a</a>). Hence, given the high prevalence of cannabis use and mental health disorders such as anxiety and depression in the Crohn's disease population, it is challenging to generalize the results of these small studies to all people with Crohn's disease. </p> <p>We must weigh the possibility of small benefit of cannabis and cannabinoids in Crohn's disease against the well‐established harms and concerns of cannabis including mental health related concerns (<a href="./references#CD012853-bbs2-0039" title="TriantafillidisJK , Merikas Em GikasA . Psychological factors and stress in inflammatory bowel disease. Expert Review of Gastroenterology and Hepatology2013;7(3):225‐38. ">Triantafillidis 2013</a>). Cannabis use is associated with increased emergency department visits in people with gastrointestinal diseases (<a href="./references#CD012853-bbs2-0013" title="GubatanJ , StallerK , BarshopK , KuoB . Cannabis abuse is increasing and associated with increased emergency department utilization in gastroenterology patients. Digestive Diseases and Sciences2016;61:1844–52. ">Gubatan 2015</a>). </p> <p>Co‐use of tobacco and cannabis is highly prevalent among cannabis users (<a href="./references#CD012853-bbs2-0033" title="SchauerGL , BergCJ , KeglerMC , DonovanDM , WindleM . Differences in tobacco product use among past month adult marijuana users and nonusers: Findings from the 2003–2012 national survey on drug use and health. Nicotine and Tobacco Research2016;18(3):281–8. ">Schauer 2016</a>; <a href="./references#CD012853-bbs2-0034" title="SchauerGL , RosenberryZR , PetersEN . Marijuana and tobacco co‐administration in blunts, spliffs, and mulled cigarettes: A systematic literature review. Addictive Behaviors2017;64:200‐11. ">Schauer 2017</a>). Tobacco smoking in people with Crohn's disease leads to increased morbidity and smoking cessation improves outcomes (<a href="./references#CD012853-bbs2-0023" title="JohnsonGJ , CosnesJ , MansfieldJC . Review article: smoking cessation as primary therapy to modify the course of Crohn’s disease. Alimentary Pharmacology and Therapeutics2005;21:921–31. ">Johnson 2005</a>). Further, there is concern that cannabis and tobacco are often combined in the same product (<a href="./references#CD012853-bbs2-0034" title="SchauerGL , RosenberryZR , PetersEN . Marijuana and tobacco co‐administration in blunts, spliffs, and mulled cigarettes: A systematic literature review. Addictive Behaviors2017;64:200‐11. ">Schauer 2017</a>). This is particularly worrisome in adolescents and young adults because of potential mental health symptoms (<a href="./references#CD012853-bbs2-0031" title="RamoDE , LiuH , ProchaskaJJ . Tobacco and marijuana use among adolescents and young adults: A systematic review of their co‐use. Clinical Psychology Review2012;32(2):105‐21. ">Ramo 2012</a>). Mental health disorders such as anxiety and depression are prevalent among people with IBD and can negatively influence the course of IBD (<a href="./references#CD012853-bbs2-0039" title="TriantafillidisJK , Merikas Em GikasA . Psychological factors and stress in inflammatory bowel disease. Expert Review of Gastroenterology and Hepatology2013;7(3):225‐38. ">Triantafillidis 2013</a>). It is not known if cannabis smoking will increase concomitant tobacco use. People with Crohn's disease who use cannabis or cannabis oil may benefit from screening for tobacco use and counselling on smoking cessation. Close monitoring for adverse events in people with Crohn's disease who use cannabis may be beneficial given the lack of robust data and conversely, the presence of large body of data suggesting evidence of harm with cannabis use (<a href="./references#CD012853-bbs2-0006" title="AsbridgeM , HaydenJA , CartwrightJL . Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta‐analysis. BMJ2012;344:e536. ">Asbridge 2012</a>; <a href="./references#CD012853-bbs2-0013" title="GubatanJ , StallerK , BarshopK , KuoB . Cannabis abuse is increasing and associated with increased emergency department utilization in gastroenterology patients. Digestive Diseases and Sciences2016;61:1844–52. ">Gubatan 2015</a>; <a href="./references#CD012853-bbs2-0015" title="HackamDG . Cannabis and stroke ‐ systematic appraisal of case reports. Stroke2015;46:852‐6. ">Hackam 2015</a>; <a href="./references#CD012853-bbs2-0033" title="SchauerGL , BergCJ , KeglerMC , DonovanDM , WindleM . Differences in tobacco product use among past month adult marijuana users and nonusers: Findings from the 2003–2012 national survey on drug use and health. Nicotine and Tobacco Research2016;18(3):281–8. ">Schauer 2016</a>). </p> </section> <section id="CD012853-sec-0066"> <h3 class="title" id="CD012853-sec-0066">Overall completeness and applicability of evidence</h3> <p>This review included three small studies with a total of 93 participants, so completeness of evidence is a concern. More research is needed to be able to draw any firm conclusions about the efficacy and safety of cannabis in people with Crohn's disease. Although the results of this review may be applicable to persons with Crohn's disease there are some concerns with applicability because the included studies excluded people with a history of mental illness, drug abuse, or previous cannabis consumption. Both cannabis use and mental illness such as depression and anxiety are prevalent among people with IBD in North America (<a href="./references#CD012853-bbs2-0017" title="HauserW , MoserG , KloseP , Mikocka‐WalusA . Psychosocial issues in evidence‐based guidelines on inflammatory bowel diseases: A review. World Journal of Gastroenterology2014;20(13):3663‐71. ">Hauser 2014</a>; <a href="./references#CD012853-bbs2-0042" title="WeissA , FriedenbergF . Patterns of cannabis use in patients with Inflammatory Bowel Disease: A population based analysis. Drug and Alcohol Dependence2015;156:84‐9. ">Weiss 2015</a>). </p> </section> <section id="CD012853-sec-0067"> <h3 class="title" id="CD012853-sec-0067">Quality of the evidence</h3> <p>The <a href="./references#CD012853-bbs2-0001" title="NaftaliT , Bar‐LevL , GabayG , ChowersY , DotanI , BronshteinM , et al. Tetrahydrocannabinol (THC) rich medical cannabis induces clinical and biochemical improvement with a steroid sparing effect in active Crohn's disease. Gastroenterology2012;1:S780. NaftaliT , Bar‐Lev SchleiderL , DotanI , LanskyEP , Sklerovsky BenjaminovF , KonikoffFM . Cannabis induces a clinical response in patients with Crohn’s disease: a prospective placebo‐controlled study. Clinical Gastroenterology and Hepatology2013;11(10):1276‐80. ">Naftali 2013a</a> study was rated as high risk of bias for blinding of participants and other bias (cannabis participants were older than placebo participants). Although the authors took care to assign placebo participants to identical placebo cigarettes, the majority of participants were able to figure out which group they were assigned to due to the psychotropic effects of cannabis. The <a href="./references#CD012853-bbs2-0002" title="NaftaliT , MechoulamR , GabayG , SteinA , BronshteinM , MariA , et al. Cannabidiol treatment does not effect active Crohn's disease. Gastroenterology2013;1:S180. NaftaliT , MechulamR , MariiA , GabayG , SteinA , BronshtainM , et al. Low‐dose cannabidiol is safe but not effective in the treatment for Crohn’s Disease, a randomized controlled trial. Digestive Diseases and Sciences2017;62:1615–20. ">Naftali 2017a</a> study was rated as high risk of bias due to other bias. Sixty per cent of cannabis participants were smokers compared to none of the placebo participants. The <a href="./references#CD012853-bbs2-0003" title="NaftaliT , SchliederLBL , KonikoffFM . The effect of cannabis on Crohn's Disease patients. International Association of Cannabis Medicine (IACM). 2017. ">Naftali 2017b</a> study was rated as low risk of bias. Our assessment based on GRADE analyses suggests that the certainty of the evidence supporting the outcomes in this review is low to very low. As a result of this uncertainty no firm conclusions regarding the efficacy and safety of cannabis for Crohn's can be drawn. </p> </section> <section id="CD012853-sec-0068"> <h3 class="title" id="CD012853-sec-0068">Potential biases in the review process</h3> <p>We performed a comprehensive literature search to minimize bias related to study selection. Two authors (TK and NC) reviewed the studies for inclusion and exclusion, extracted data independently, and reviewed study quality. Limitations of this systematic review include a small number of studies with a small number of participants and sparse data. Two of the included studies were judged to be at high risk of bias (<a href="./references#CD012853-bbs2-0001" title="NaftaliT , Bar‐LevL , GabayG , ChowersY , DotanI , BronshteinM , et al. Tetrahydrocannabinol (THC) rich medical cannabis induces clinical and biochemical improvement with a steroid sparing effect in active Crohn's disease. Gastroenterology2012;1:S780. NaftaliT , Bar‐Lev SchleiderL , DotanI , LanskyEP , Sklerovsky BenjaminovF , KonikoffFM . Cannabis induces a clinical response in patients with Crohn’s disease: a prospective placebo‐controlled study. Clinical Gastroenterology and Hepatology2013;11(10):1276‐80. ">Naftali 2013a</a>; <a href="./references#CD012853-bbs2-0002" title="NaftaliT , MechoulamR , GabayG , SteinA , BronshteinM , MariA , et al. Cannabidiol treatment does not effect active Crohn's disease. Gastroenterology2013;1:S180. NaftaliT , MechulamR , MariiA , GabayG , SteinA , BronshtainM , et al. Low‐dose cannabidiol is safe but not effective in the treatment for Crohn’s Disease, a randomized controlled trial. Digestive Diseases and Sciences2017;62:1615–20. ">Naftali 2017a</a>). In addition, all three eligible studies were conducted by the same investigator (Naftali). </p> </section> <section id="CD012853-sec-0069"> <h3 class="title" id="CD012853-sec-0069">Agreements and disagreements with other studies or reviews</h3> <p>We found two systematic reviews that assessed the use of cannabis in Crohn's disease (<a href="./references#CD012853-bbs2-0027" title="LanghorstJ , WulfertH , LaucheR , KloseP , CramerH , DobosGJ , et al. Systematic review of complementary and alternative medicine treatments in inflammatory bowel diseases. Journal of Crohn's and Colitis2015;9(1):86‐106. ">Langhorst 2015</a>; <a href="./references#CD012853-bbs2-0041" title="VolzMS , SiegmundB , HauserW . Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review. Schmerz2016;30(1):37‐46. ">Volz 2016</a>). <a href="./references#CD012853-bbs2-0027" title="LanghorstJ , WulfertH , LaucheR , KloseP , CramerH , DobosGJ , et al. Systematic review of complementary and alternative medicine treatments in inflammatory bowel diseases. Journal of Crohn's and Colitis2015;9(1):86‐106. ">Langhorst 2015</a> assessed all complementary and alternative medical treatments for inflammatory bowel disease and <a href="./references#CD012853-bbs2-0041" title="VolzMS , SiegmundB , HauserW . Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review. Schmerz2016;30(1):37‐46. ">Volz 2016</a> assessed the use of cannabis in inflammatory bowel disease, irritable bowel syndrome and chronic pancreatitis. Both reviews included the <a href="./references#CD012853-bbs2-0001" title="NaftaliT , Bar‐LevL , GabayG , ChowersY , DotanI , BronshteinM , et al. Tetrahydrocannabinol (THC) rich medical cannabis induces clinical and biochemical improvement with a steroid sparing effect in active Crohn's disease. Gastroenterology2012;1:S780. NaftaliT , Bar‐Lev SchleiderL , DotanI , LanskyEP , Sklerovsky BenjaminovF , KonikoffFM . Cannabis induces a clinical response in patients with Crohn’s disease: a prospective placebo‐controlled study. Clinical Gastroenterology and Hepatology2013;11(10):1276‐80. ">Naftali 2013a</a> study and both reviews had similar conclusions. <a href="./references#CD012853-bbs2-0027" title="LanghorstJ , WulfertH , LaucheR , KloseP , CramerH , DobosGJ , et al. Systematic review of complementary and alternative medicine treatments in inflammatory bowel diseases. Journal of Crohn's and Colitis2015;9(1):86‐106. ">Langhorst 2015</a> concluded that complementary and alternative therapies might be effective for the treatment of inflammatory bowel disease. <a href="./references#CD012853-bbs2-0041" title="VolzMS , SiegmundB , HauserW . Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review. Schmerz2016;30(1):37‐46. ">Volz 2016</a> concluded that cannabis may be useful for symptom relief. Studies with higher methodological quality and larger numbers of participants are required to allow for more definitive conclusions on the efficacy and safety of cannabis for Crohn's disease. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD012853-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/urn:x-wiley:14651858:media:CD012853:CD012853-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/image_t/tCD012853-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Flow diagram." data-id="CD012853-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/image_n/nCD012853-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/full#CD012853-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/image_n/nCD012853-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012853-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/urn:x-wiley:14651858:media:CD012853:CD012853-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/image_t/tCD012853-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012853-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/image_n/nCD012853-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/full#CD012853-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/image_n/nCD012853-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012853-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/urn:x-wiley:14651858:media:CD012853:CD012853-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/image_t/tCD012853-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Cannabis cigarettes (115 mg THC) versus placebo cigarettes, Outcome 1 Clinical remission at 8 weeks." data-id="CD012853-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/image_n/nCD012853-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Cannabis cigarettes (115 mg THC) versus placebo cigarettes, Outcome 1 Clinical remission at 8 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/references#CD012853-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/image_n/nCD012853-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012853-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/urn:x-wiley:14651858:media:CD012853:CD012853-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/image_t/tCD012853-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Cannabis cigarettes (115 mg THC) versus placebo cigarettes, Outcome 2 Clinical response at 8 weeks." data-id="CD012853-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/image_n/nCD012853-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Cannabis cigarettes (115 mg THC) versus placebo cigarettes, Outcome 2 Clinical response at 8 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/references#CD012853-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/image_n/nCD012853-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012853-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/urn:x-wiley:14651858:media:CD012853:CD012853-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/image_t/tCD012853-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Cannabis cigarettes (115 mg THC) versus placebo cigarettes, Outcome 3 Adverse events." data-id="CD012853-fig-0005" src="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/image_n/nCD012853-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Cannabis cigarettes (115 mg THC) versus placebo cigarettes, Outcome 3 Adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/references#CD012853-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/image_n/nCD012853-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012853-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/urn:x-wiley:14651858:media:CD012853:CD012853-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/image_t/tCD012853-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Cannabis cigarettes (115 mg THC) versus placebo cigarettes, Outcome 4 Decrease in CRP of more than 0.5 mg/dL from week 0 to week 8." data-id="CD012853-fig-0006" src="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/image_n/nCD012853-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Cannabis cigarettes (115 mg THC) versus placebo cigarettes, Outcome 4 Decrease in CRP of more than 0.5 mg/dL from week 0 to week 8. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/references#CD012853-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/image_n/nCD012853-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012853-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/urn:x-wiley:14651858:media:CD012853:CD012853-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/image_t/tCD012853-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Cannabis oil (5% cannabidiol sublingual oil) versus placebo oil, Outcome 1 Clinical remission at 8 weeks." data-id="CD012853-fig-0007" src="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/image_n/nCD012853-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Cannabis oil (5% cannabidiol sublingual oil) versus placebo oil, Outcome 1 Clinical remission at 8 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/references#CD012853-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/image_n/nCD012853-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012853-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/urn:x-wiley:14651858:media:CD012853:CD012853-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/image_t/tCD012853-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Cannabis oil (5% cannabidiol sublingual oil) versus placebo oil, Outcome 2 Serious adverse events." data-id="CD012853-fig-0008" src="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/image_n/nCD012853-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Cannabis oil (5% cannabidiol sublingual oil) versus placebo oil, Outcome 2 Serious adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/references#CD012853-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/image_n/nCD012853-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012853-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/urn:x-wiley:14651858:media:CD012853:CD012853-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/image_t/tCD012853-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Cannabis oil (15% cannabidiol and 4% THC) versus placebo oil, Outcome 1 Quality of life at 8 weeks." data-id="CD012853-fig-0009" src="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/image_n/nCD012853-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Cannabis oil (15% cannabidiol and 4% THC) versus placebo oil, Outcome 1 Quality of life at 8 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/references#CD012853-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/image_n/nCD012853-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012853-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/urn:x-wiley:14651858:media:CD012853:CD012853-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/image_t/tCD012853-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Cannabis oil (15% cannabidiol and 4% THC) versus placebo oil, Outcome 2 CDAI at 8 weeks." data-id="CD012853-fig-0010" src="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/image_n/nCD012853-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Cannabis oil (15% cannabidiol and 4% THC) versus placebo oil, Outcome 2 CDAI at 8 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/references#CD012853-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/media/CDSR/CD012853/image_n/nCD012853-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD012853-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Cannabis cigarettes (115 mg THC) compared to placebo cigarettes for the treatment of active Crohn's disease</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Cannabis cigarettes (115 mg THC) compared to placebo cigarettes for the treatment of active Crohn's disease</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> participants with active Crohn's disease<br/> <b>Setting:</b> outpatient<br/> <b>Intervention:</b> Cannabis cigarettes (115 mg THC)<br/> <b>Comparison:</b> placebo cigarettes </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo cigarettes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with cannabis cigarettes (115 mg THC)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of patients achieving clinical remission</p> <p>Follow‐up: 8 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>100 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>455 per 1,000<br/> (63 to 1,000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 4.55<br/> (0.63 to 32.56) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Remission was defined as a CDAI score &lt; 150</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of patients achieving clinical response</p> <p>Follow‐up: 8 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>400 per 1,000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>908 per 1,000<br/> (416 to 1,000) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 2.27<br/> (1.04 to 4.97) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21<br/> (1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Response was defined as a 100‐point reduction of CDAI from baseline</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CRP (mg/dL) at end of study</p> <p>Follow‐up: 8 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>200 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>272 per 1,000<br/> (56 to 1,000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.36<br/> (0.28 to 6.56) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>4 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This study reported on the proportion of participants with a decrease in CRP of more than 0.5mg/dL from week 0 to week 8 </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life</p> <p>Short‐Form 36 health survey (SF‐36)</p> <p>Follow‐up: 8 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SF‐36 scores range from 0 to 100 with a higher score indicating better quality of life </p> <p>This study reported a 28 point increase in the SF‐36 score from baseline in the cannabis group compared to a 5 point increase in the placebo group (standard deviations were not reported) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> <p>Follow‐up: 8 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>200 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>818 per 1,000<br/> (230 to 1,000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 4.09<br/> (1.15 to 14.57) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events included sleepiness, nausea, difficulty with concentration, memory loss, confusion and dizziness </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>This outcome was not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Withdrawal due to adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>This outcome was not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>CDAI: Crohn's disease activity index</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded one level due to high risk of bias for blinding of participants and other bias (cannabis participants were about 10 years older than placebo participants) </p> <p><sup>2</sup> Downgraded two levels due to very serious imprecision (6 events) </p> <p><sup>3</sup> Downgraded two levels due to very serious imprecision (14 events) </p> <p><sup>4</sup> We did not downgrade for risk of bias as this would have no impact on CRP which is an objective outcome </p> <p><sup>5</sup> Downgraded two levels due to very serious imprecision (5 events) </p> <p><sup>6</sup> Downgraded two levels due to very serious imprecision (11 events) </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Cannabis cigarettes (115 mg THC) compared to placebo cigarettes for the treatment of active Crohn's disease</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/full#CD012853-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012853-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Cannabis oil (5% cannabidiol sublingual oil) compared to placebo oil for the treatment of active Crohn's disease</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Cannabis oil (5% cannabidiol sublingual oil) compared to placebo for the treatment of active Crohn's disease</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> participants with active Crohn's disease<br/> <b>Setting:</b> outpatient<br/> <b>Intervention:</b> cannabis oil (5% cannabidiol sublingual oil)<br/> <b>Comparison:</b> placebo oil (olive oil) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with cannabis oil (5% cannabidiol sublingual oil)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of patients achieving clinical remission</p> <p>Follow‐up: 8 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>333 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>400 per 1,000<br/> (120 to 1,000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.20<br/> (0.36 to 3.97) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Remission was defined as a CDAI score &lt; 150</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of patients achieving clinical response</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>This outcome was not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CRP (mg/dL) at end of study</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>This outcome was not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Quality of life</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>This outcome was not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse events</p> <p>Follow‐up: 8 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>See comments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse events were rated on a scale from one to seven and included headache, sleepiness, nausea and dizziness </p> <p>The proportion of participants in each group who had an adverse event was not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious adverse events</p> <p>Follow‐up: 8 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>111 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>100 per 1,000<br/> (8 to 1,000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.90<br/> (0.07 to 12.38) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was one serious adverse event in each group. Both were worsening Crohn's disease that required rescue intervention </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Withdrawal due to adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>This outcome was not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded one level due to high risk of bias for other bias (60% of cannabis participants were smokers compared to none of the placebo participants) </p> <p><sup>2</sup> Downgraded two levels due to very serious imprecision (7 events) </p> <p><sup>3</sup> Downgraded two levels due to very serious imprecision (2 events) </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Cannabis oil (5% cannabidiol sublingual oil) compared to placebo oil for the treatment of active Crohn's disease</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/full#CD012853-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012853-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Cannabis oil (15% cannabidiol and 4% THC) compared to placebo oil for the treatment of active Crohn's disease</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Cannabis oil (15% cannabidiol and 4% THC) compared to placebo oil for the treatment of active Crohn's disease</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> participants with active Crohn's disease<br/> <b>Setting:</b> outpatient<br/> <b>Intervention:</b> cannabis oil (15% cannabidiol and 4% THC)<br/> <b>Comparison:</b> placebo oil (olive oil) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo oil</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with cannabis oil (15% cannabidiol and 4% THC)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of patients achieving clinical remission</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>This outcome was not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of patients achieving clinical response</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>This outcome was not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CRP (mg/dL) at end of study</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>This outcome was not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life</p> <p>Short‐Form 36 health survey (SF‐36)</p> <p>Follow‐up: 8 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean SF‐36 score at 8 weeks was 79.9</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 16.4 higher<br/> (5.72 higher to 27.08 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SF‐36 scores range from 0 to 100 with a higher score indicating better quality of life </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This outcome was not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>This outcome was not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Withdrawal due to adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>This outcome was not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded two levels due to very serious imprecision (39 participants) </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Cannabis oil (15% cannabidiol and 4% THC) compared to placebo oil for the treatment of active Crohn's disease</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/full#CD012853-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012853-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Cannabis cigarettes (115 mg THC) versus placebo cigarettes</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinical remission at 8 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Clinical response at 8 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Decrease in CRP of more than 0.5 mg/dL from week 0 to week 8 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Cannabis cigarettes (115 mg THC) versus placebo cigarettes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/references#CD012853-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012853-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Cannabis oil (5% cannabidiol sublingual oil) versus placebo oil</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinical remission at 8 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Serious adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Cannabis oil (5% cannabidiol sublingual oil) versus placebo oil</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/references#CD012853-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012853-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Cannabis oil (15% cannabidiol and 4% THC) versus placebo oil</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Quality of life at 8 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 CDAI at 8 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Cannabis oil (15% cannabidiol and 4% THC) versus placebo oil</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012853.pub2/references#CD012853-tbl-0006">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD012853.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD012853-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD012853-note-0005">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD012853-note-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="hr#CD012853-note-0004">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD012853-note-0003">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD012853-note-0002">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD012853-note-0011">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012853\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012853\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012853\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012853\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012853\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012853\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012853\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012853\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012853\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012853\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012853\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012853\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012853\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012853\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012853\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012853\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012853\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012853\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=fw9sVDQH&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012853.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012853.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD012853.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD012853.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012853.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740725722478"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012853.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740725722482"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012853.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e822c5e8b936d',t:'MTc0MDcyNTcyMi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 